1. Antibody-drug Conjugate/ADC Related
    Cell Cycle/DNA Damage
    Cytoskeleton
  2. ADC Cytotoxin
    Microtubule/Tubulin

Paclitaxel 

Cat. No.: HY-B0015 Purity: 99.46%
Data Sheet SDS Handling Instructions

Paclitaxel is a potent anticancer agent known to promote microtubule (MT) assembly, inhibit MT depolymerization, and change MT dynamics required for mitosis and cell proliferation.

For research use only. We do not sell to patients.
Paclitaxel Chemical Structure

Paclitaxel Chemical Structure

CAS No. : 33069-62-4

Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
50 mg $50 In-stock
100 mg $80 In-stock
500 mg $120 In-stock
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

Paclitaxel is a potent anticancer agent known to promote microtubule (MT) assembly, inhibit MT depolymerization, and change MT dynamics required for mitosis and cell proliferation.

IC50 & Target

IC50: 4 nM (MT)

In Vitro

Paclitaxel at 0.1, 0.5, and 1 μM reduces the proliferation and survival of CCRF-HSB-2 cells in a dose-dependent fashion and that the IC50 value of taxol is about 0.25 μM[1]. Paclitaxel directly associates with the endoplasmic reticulum to stimulate the release of calcium into the cytosol, contributing to the induction of apoptosis[2].

In Vivo

In a SCID mouse xenograft model, low dose metronomic Paclitaxel treatment decreases lung dissemination of EGI-1 cells without significantly affecting their local tumor growth[3]. Low doses of paclitaxel promot liver metastasis in mouse xenografts, which correlats with changes in estrogen metabolism in the host liver[4]. Paclitaxel (2 mg/kg per treatment, black circles) induces mechanical hypersensitivity in the glabrous skin of the hindpaw[5].

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT03096418 University of Wisconsin, Madison|National Cancer Institute (NCI) Breast Neoplasm Female March 13, 2017
NCT02762981 Corcept Therapeutics Solid Tumors|Cellular Diagnosis, Ovarian Epithelial Cancer|Breast Cancer March 2016 Phase 1|Phase 2
NCT00583349 Columbia University|Celgene Corporation Bladder Cancer December 2007 Phase 1|Phase 2
NCT01746225 International Breast Cancer Study Group|Breast International Group Metastatic Breastcancer April 2013 Phase 2
NCT02193633 Royal Marsden NHS Foundation Trust|Institute of Cancer Research, United Kingdom|AstraZeneca Advanced Cancer April 2013 Phase 1
NCT01583426 German Breast Group|Celgene Corporation|Roche Pharma AG Tubular Breast Cancer Stage II|Mucinous Breast Cancer Stage II|Breast Cancer Female NOS|Invasive Ductal Breast Cancer|Tubular Breast Cancer Stage III|HER-2 Positive Breast Cancer|Inflammatory Breast Cancer Stage IV|Inflammatory Breast Cancer July 2012 Phase 3
NCT01962103 Celgene Neuroblastoma|Rhabdomyosarcoma|Ewing's Sarcoma|Ewing's Tumor|Sarcoma, Ewing's|Sarcomas, Epitheliod|Sarcoma, Soft Tissue|Sarcoma, Spindle Cell|Melanoma|Malignant Melanoma|Clinical Oncology|Oncology, Medical|Pediatrics, Osteosarcoma|Osteogenic Sarcoma|Osteosarcoma Tumor|Sarcoma, Osteogenic|Tumors|Cancer|Neoplasia|Neoplasm|Histiocytoma|Fibrosarcoma|Dermatofibrosarcoma December 4, 2013 Phase 1|Phase 2
NCT01442974 Grupo Hospital de Madrid Pancreatic Cancer January 2011
NCT01969955 Chinese Academy of Medical Sciences Squamous Cell Carcinoma of Lung September 2013 Phase 2
NCT02551432 Seoul National University Hospital Small Cell Lung Cancer September 2015 Phase 2
NCT02389985 NewLink Genetics Corporation Ovarian Cancer July 2015 Phase 1|Phase 2
NCT02033538 Zhejiang University Squamous Cell Carcinoma of Esophagus January 2014 Phase 2
NCT00508326 M.D. Anderson Cancer Center Advanced Cancer October 2005 Phase 1
NCT02157870 M.D. Anderson Cancer Center|National Institutes of Health (NIH)|National Cancer Institute (NCI) Ovarian Cancer December 2004 Phase 2
NCT01994031 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Solid Tumors August 2014 Phase 4
NCT01497470 OncoGenex Technologies|Teva Pharmaceutical Industries Cancer April 2012 Phase 1
NCT00102622 M.D. Anderson Cancer Center|National Institutes of Health (NIH)|National Cancer Institute (NCI) Ovarian Cancer December 2004 Phase 1
NCT02262897 Tongji University Small Cell Lung Cancer September 2013 Phase 2
NCT01431794 Sidney Kimmel Comprehensive Cancer Center|Novartis Resectable Pancreatic Adenocarcinoma September 2011 Phase 1|Phase 2
NCT01973309 OncoMed Pharmaceuticals, Inc. Metastatic Breast Cancer September 2013 Phase 1
NCT02415023 Hutchison Medipharma Limited Gastric Cancer September 2014 Phase 1|Phase 2
NCT01209195 Merrimack Pharmaceuticals|Sanofi Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,|Primary Peritoneal Cancer or Endometrial Cancer|Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer October 2010 Phase 1
NCT02054884 Philogen S.p.A.|immatics Biotechnologies GmbH Merkel Cell Carcinoma October 2013 Phase 2
NCT01954355 Swiss Group for Clinical Cancer Research Solid Tumor|Ovarian Cancer September 2013 Phase 1
NCT02707159 Helse Stavanger HF Metastatic Pancreatic Cancer November 2014 Phase 2
NCT00453076 Asan Medical Center Bile Duct Obstruction November 2006 Phase 3
NCT00820170 Memorial Sloan Kettering Cancer Center|Bristol-Myers Squibb Breast Cancer January 2009 Phase 1|Phase 2
NCT02076243 Icahn School of Medicine at Mount Sinai|Celgene Corporation Cutaneous Squamous Cell Carcinoma March 2014 Phase 2
NCT01953445 Washington University School of Medicine Breast Neoplasms August 2014 Phase 2
NCT01133912 Jungsil Ro|GlaxoSmithKline|CJ HealthCare Corporation|National Cancer Center, Korea Breast Cancer March 2009 Phase 1
NCT01702844 UNC Lineberger Comprehensive Cancer Center|Celgene Non Small Cell Lung Cancer (NSCLC) October 2012 Phase 2
NCT01698710 Massachusetts General Hospital Pancreatic Cysts November 2012
NCT02788708 Floor Backes|Eisai Inc.|Ohio State University Comprehensive Cancer Center Fallopian Tube Carcinoma|Recurrent Ovarian Cancer|Primary Peritoneal Carcinoma|Recurrent Endometrial Cancer May 27, 2016 Phase 1
NCT02684227 M.D. Anderson Cancer Center|Astellas Pharma Inc|Medivation, Inc.|National Comprehensive Cancer Network Endometrial Cancer August 2016 Phase 2
NCT01107665 University of California, Irvine|GlaxoSmithKline Stage III Melanoma|Stage IV Melanoma|Unresectable Melanoma August 2010 Phase 2
NCT00933374 Heinrich-Heine University, Duesseldorf Bladder Cancer July 2009 Phase 2
NCT02280252 New York University School of Medicine Breast Cancer March 2005 Phase 2
NCT02251951 Hellenic Oncology Research Group Stomach and Gastro-Esophageal Junction (GEJ) Cancer September 2012 Phase 2
NCT00532285 National Cancer Center, Korea Breast Cancer September 2005 Phase 2
NCT01992341 Amgen Advanced Solid Tumors July 2012 Phase 1
NCT02279576 Spanish Oncology Genito-Urinary Group Penile Squamous Cell Carcinoma Stage IV January 2015 Phase 2
NCT02555696 Celgene Metastatic Breast Cancer May 31, 2012
NCT02023021 Xian-Jun Yu|Fudan University Stage IA Pancreatic Adenocarcinoma|Stage IB Pancreatic Adenocarcinoma|Stage IIA Pancreatic Adenocarcinoma|Stage IIB Pancreatic Adenocarcinoma January 2014 Phase 2
NCT02273713 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Celgene Corporation Esophageal Cancer|Toxicity October 2014 Phase 1|Phase 2
NCT02016209 Zhejiang University Non Small Cell Lung Cancer January 2014 Phase 2
NCT02476955 ArQule Solid Tumors|Ovarian Cancer|Endometrial Cancer June 2015 Phase 1
NCT00672295 AA Secord|Duke University Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer August 2007 Phase 1
NCT02358161 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Novartis|Celgene Corporation Pancreatic Cancer September 2013 Phase 1|Phase 2
NCT01016769 Memorial Sloan Kettering Cancer Center|NATL COMP CA NETWORK|Pfizer Squamous Cell Cancer|Head and Neck Cancer November 2009 Phase 1|Phase 2
NCT01039844 M.D. Anderson Cancer Center|Luitpold Pharmaceuticals Melanoma December 2009 Phase 1
NCT00487669 Dartmouth-Hitchcock Medical Center|CTI BioPharma Advanced Non-small Cell Lung Cancer October 2006 Phase 2
NCT01444547 Chinese Academy of Medical Sciences|Beijing Municipal Science & Technology Commission Esophageal Cancer January 2007 Phase 2
NCT00933426 M.D. Anderson Cancer Center|Celgene Corporation Prostate Cancer August 2009 Phase 1
NCT01432223 Osaka Medical College Breast Cancer|HER-2 Positive Breast Cancer|Effects of Chemotherapy September 2011 Phase 2
NCT02733250 Centre hospitalier de l'Université de Montréal (CHUM)|Centre de Recherche du Centre Hospitalier de l'Université de Montréal|Merck Canada Inc|Celgene Inc|Jewish General Hospital Lung Cancer March 13, 2017 Phase 1|Phase 2
NCT02075021 New York University School of Medicine|Celgene Corporation Relapsed or Refractory Multiple Myeloma March 2014 Phase 1|Phase 2
NCT01525706 Lawson Health Research Institute|University of Western Ontario, Canada Mucinous Cystic Tumor With Moderate Dysplasia|Mucinous Cystadenoma of Pancreas|Mucinous Cystadenocarcinoma of Pancreas|Benign Neoplasm of Pancreas September 2012 Phase 1
NCT01134250 Philogen S.p.A. Solid Tumour,|Breast Cancer,|Metastatic Melanoma,|Non-small Cell Lung Cancer (NSCLC), June 2008 Phase 1|Phase 2
NCT02230319 Medical Oncology & Hematology Associates of Northern Virginia|Inova Health System Breast Cancer October 2014 Phase 2
NCT00833807 M.D. Anderson Cancer Center|Celgene Corporation Melanoma|Liver Metastasis February 2009 Phase 1
NCT02887248 SCRI Development Innovations, LLC|Celgene Urothelial Carcinoma|Bladder Cancer|Transitional Cell Carcinoma January 12, 2017 Phase 2
NCT00736619 Memorial Sloan Kettering Cancer Center|Celgene Corporation|National Comprehensive Cancer Network HEAD & NECK Cancer August 2008 Phase 1
NCT00731861 Indiana University School of Medicine|Novartis|Indiana University Neoplasm Metastasis|Carcinoma May 2005 Phase 1
NCT03166085 Memorial Sloan Kettering Cancer Center|Samus Therapeutics, Inc. Metastatic Breast Cancer May 23, 2017 Phase 1
NCT02151149 Celgene Corporation Non-Small Cell Lung Cancer|Carcinoma|Squamous Cell Carcinoma|Adenocarcinoma|Carcinoma, Large Cell|Lung Neoplasm June 2014 Phase 4
NCT00506779 M.D. Anderson Cancer Center Uterine Cancer December 2003 Phase 1|Phase 2
NCT01303497 Centre Oscar Lambret|Groupe Sarcome Français|Groupe d’études des Tumeurs Osseuses Angiosarcoma September 2010 Phase 2
NCT01822314 Fondazione Michelangelo Breast Cancer April 2013 Phase 3
NCT01872403 The First Affiliated Hospital of Guangzhou Medical University Non-small Cell Lung Cancer October 2012 Phase 2
NCT02379416 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Solid Tumors February 20, 2015 Phase 1
NCT00970580 Biogen Non-Small Cell Lung Cancer October 2009 Phase 1
NCT01764087 Hanmi Pharmaceutical Company Limited Unspecified Adult Solid Tumor, Protocol Specific|Gastric Cancer|Breast Cancer December 2012 Phase 1|Phase 2
NCT01015222 M.D. Anderson Cancer Center Advanced Cancer November 2009 Phase 1
NCT01258192 Zhejiang Cancer Hospital|Second Affiliated Hospital, School of Medicine, Zhejiang University Esophageal Squamous Cell Carcinoma January 2011 Phase 2
NCT01253681 Amgen Carcinoma|Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer November 2010 Phase 1
NCT01636622 M.D. Anderson Cancer Center Advanced Cancers July 2012 Phase 1
NCT01667211 Chinese Academy of Medical Sciences Uterine Cervical Cancer November 2011 Phase 2
NCT00900627 AstraZeneca Neoplasms|Breast Neoplasms|Breast Cancer June 2009 Phase 1|Phase 2
NCT02530489 M.D. Anderson Cancer Center|Genentech, Inc. Breast Cancer February 4, 2016 Phase 2
NCT02124317 Chinese PLA General Hospital Advanced Pancreatic Cancer April 2014 Phase 2
NCT02545010 National University Hospital, Singapore Ovarian Cancer September 2015 Phase 1
NCT02769832 Muhammad Furqan|Celgene Corporation|University of Iowa Small Cell Lung Cancer (SCLC) August 2016 Phase 2
NCT01701349 Mateon Therapeutics Anaplastic Thyroid Cancer March 2015 Phase 3
NCT01830244 Barwon Health Breast Cancer April 2013 Phase 2
NCT02241551 University of Pittsburgh Borderline Resectable Pancreatic Cancer December 2014 Phase 2
NCT01454778 Patrick Kelly|Sanford Health Peripheral Vascular Disease April 2011
NCT01203267 Shanghai Jiao Tong University School of Medicine|Fudan University|Ruijin Hospital Breast Cancer December 2007 Phase 2
NCT01757288 University of Texas Southwestern Medical Center|Celgene STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER March 2013 Phase 1|Phase 2
NCT02776917 Barbara Parker, MD|University of California, San Diego Breast Neoplasms January 2018 Phase 1
NCT02244502 NovoCure Ltd. Ovarian Carcinoma September 2014 Phase 1|Phase 2
NCT02229045 Sun Yat-sen University Gastric Caner November 2010 Phase 2
NCT01839487 Halozyme Therapeutics Metastatic Pancreatic Cancer April 2013 Phase 2
NCT02017015 Celgene Corporation Pancreatic Neoplasms December 2013 Phase 2
NCT02486601 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|Celgene Corporation Cancer of Stomach June 2015 Phase 2
NCT02051751 Novartis Pharmaceuticals|Novartis Neoplasms, Breast Neoplasms, Head and Neck Neoplasms March 5, 2014 Phase 1
NCT02135822 Chinese PLA General Hospital Advanced Pancreatic Cancer May 2014 Phase 2
NCT00322881 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Mixed Tumor, Mesodermal April 2006 Phase 2
NCT00891605 Abbott|Genentech, Inc. Solid Tumors July 2009 Phase 1
NCT00772798 Herlev Hospital|Odense University Hospital Ovarian Cancer June 2007 Phase 2
NCT01113476 M.D. Anderson Cancer Center Advanced Cancer April 27, 2010 Phase 1
NCT02501902 Pfizer|Celgene Metastatic Pancreatic Ductal Adenocarcinoma November 2015 Phase 1
NCT01374620 Centre Oscar Lambret Cancer June 2011 Phase 1
NCT02064829 Sorrento Therapeutics, Inc. Metastatic Breast Cancer|Locally Recurrent Breast Cancer March 2014
NCT02059876 Guangdong General Hospital Breast Cancer November 2013 Phase 2
NCT00585052 University of Iowa Ovarian Cancer August 2003 Phase 2
NCT02317991 SCRI Development Innovations, LLC|Celgene Gastroesophageal Cancer May 5, 2015 Phase 2
NCT00961181 Biotronik AG In-stent Coronary Artery Restenosis August 2009
NCT02405910 West Virginia University|Celgene Corporation Non-small Cell Lung Cancer Phase 2
NCT01982448 Dana-Farber Cancer Institute|Myriad Genetics, Inc.|Translational Breast Cancer Research Consortium Triple Negative Breast Cancer February 2014 Phase 2
NCT01814163 Spanish Lung Cancer Group Nonsquamous Nonsmall Cell Neoplasm of Lung February 2011
NCT01240655 Novartis Pharmaceuticals|Novartis Solid Tumors April 2011 Phase 1
NCT00807573 Memorial Sloan Kettering Cancer Center Lung Cancer December 2008 Phase 2
NCT01070706 Jungsil Ro|Pfizer|CJ HealthCare Corporation|National Cancer Center, Korea Breast Cancer March 2009 Phase 1|Phase 2
NCT01641783 Yanqiao Zhang|The Third Affiliated Hospital of Harbin Medical University Gastric Adenocarcinoma July 2012 Phase 2
NCT02134067 Taiho Oncology, Inc. Advanced Solid Tumors August 2014 Phase 1
NCT02181634 PrECOG, LLC.|Celgene Corporation Cholangiocarcinoma December 9, 2014 Phase 2
NCT02383251 ARCAGY/ GINECO GROUP|Novartis Ovarian Cancer June 2015 Phase 2
NCT02058667 University of Kentucky Breast Cancer July 2014 Phase 1
NCT02752685 New York University School of Medicine Breast Cancer June 2016
NCT02274012 Columbia University|Boehringer Ingelheim HER-2 Positive Gastric Cancer|Gastrooesophageal Cancer|Esophageal Cancer May 29, 2014 Phase 2
NCT00666692 Abbott Non-small Cell Lung Cancer April 2008 Phase 1
NCT02226757 VU University Medical Center NSCLC|HER2-expression|EGFR-mutation August 2014 Phase 2
NCT01179269 Loyola University|GlaxoSmithKline Non-small Cell Lung Cancer March 2010 Phase 2
NCT02272738 Osaka Medical Center for Cancer and Cardiovascular Diseases Pancreatic Cancer August 2013 Phase 1
NCT00717340 AVEO Pharmaceuticals, Inc. Metastatic Breast Cancer February 2009 Phase 1
NCT01515306 Eli Lilly and Company Malignant Solid Tumor July 2012 Phase 2
NCT02730247 Liza Villaruz, MD|University of Pittsburgh Non-small Cell Lung Cancer April 2017 Phase 2
NCT01306942 Spanish Breast Cancer Research Group|Bristol-Myers Squibb Breast Cancer July 2011 Phase 1|Phase 2
NCT00840450 New York University School of Medicine|Novartis Ovarian Cancer April 2007 Phase 2
NCT01333852 Lucas Vieira dos Santos|Fundação de Amparo à Pesquisa do Estado de São Paulo|University of Campinas, Brazil|Barretos Cancer Hospital Head and Neck Neoplasms|Squamous Cell Carcinoma February 2011 Phase 2
NCT02594371 Kinex Pharmaceuticals Inc Metastatic Breast Cancer December 2015 Phase 3
NCT02289456 Celgene Carcinoma, Non-Small-Cell Lung April 28, 2015 Phase 2
NCT02788981 University of Chicago Breast Cancer March 28, 2017 Phase 2
NCT00654758 Abbott Non-small Cell Lung Cancer December 2007 Phase 1
NCT02215447 Barwon Health|Specialised Therapeutics Australia|Deakin University|Australasian Gastro-Intestinal Trials Group Gastrointestinal Neuroendocrine Carcinomas May 2015 Phase 2
NCT00289835 Laval University|Boston Scientific Corporation Coronary Artery Bypass Grafting February 2006 Phase 4
NCT00096668 OncoGenex Technologies Breast Cancer October 2004 Phase 2
NCT02338115 University of Michigan Cancer Center Breast Cancer May 2014
NCT01405235 Institut fuer Frauengesundheit|GlaxoSmithKline|Schantl Pharma Service, Germany Recurrent, Persistent or Metastasized Cervical Cancer September 2006 Phase 3
NCT02229058 Sun Yat-sen University Gastric Cancer November 2010 Phase 2
NCT03085056 Memorial Sloan Kettering Cancer Center|Novartis Anaplastic Thyroid Cancer March 15, 2017 Early Phase 1
NCT00254891 Pfizer Carcinoma, Non-Small-Cell Lung November 2005 Phase 3
NCT02250326 Celgene Carcinoma, Non-Small-Cell Lung January 7, 2015 Phase 2
NCT01171170 Dutch Society of Physicians for Pulmonology and Tuberculosis Non Small Cell Lung Cancer September 2010 Phase 2
NCT00606515 Shandong Luye Pharmaceutical Co., Ltd.|Nanjing Sike Pharmaceutical Co., Ltd. Cancer February 2008 Phase 4
NCT00622466 University of Texas Southwestern Medical Center Breast Cancer October 2007 Phase 2
NCT00611962 Sanofi Neoplasms, Germ Cell and Embryonal December 2000 Phase 2
NCT01011075 New Mexico Cancer Care Alliance|Fred Hutchinson Cancer Research Center|Novartis Non-small Cell Lung Cancer August 2009 Phase 2
NCT00124943 Celgene Corporation|Celgene Coronary Restenosis July 2005 Phase 1|Phase 2
NCT00268970 Agennix Non-small Cell Lung Cancer December 2005 Phase 2
NCT02406170 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Esophageal Neoplasms|Stomach Neoplasms|Neoplasm Metastasis April 2015 Phase 1|Phase 2
NCT00652119 M.D. Anderson Cancer Center|Genentech, Inc.|National Cancer Institute (NCI) Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer February 2008
NCT02737709 Sun Yat-sen University Non-small Cell Lung Cancer March 2016 Phase 2
NCT00350025 Fox Chase Cancer Center|Bristol-Myers Squibb Urologic Neoplasm August 2006 Phase 2
NCT00531687 Rigshospitalet, Denmark Testicular Cancer September 2007 Phase 2
NCT01778803 Verastem, Inc. Ovarian Cancer February 26, 2013 Phase 1
NCT02005315 OncoMed Pharmaceuticals, Inc. Pancreatic Cancer|Stage IV Pancreatic Cancer September 2013 Phase 1
NCT01522768 Memorial Sloan Kettering Cancer Center|Boehringer Ingelheim|University of Southern California|Dana-Farber Cancer Institute|United States Department of Defense Esophageal Cancer|Gastric Cancer March 2012 Phase 2
NCT01617668 Novartis Pharmaceuticals|Novartis Breast Cancer August 2012 Phase 2
NCT01091428 Millennium Pharmaceuticals, Inc.|Takeda Ovarian Carcinoma|Fallopian Tube Cancer|Peritoneal Cancer|Breast Carcinoma May 2010 Phase 2
NCT01608009 Imperial College London|GlaxoSmithKline Ovarian Neoplasm July 2012 Phase 1
NCT02267707 Celgene Corporation|Celgene Pancreatic Neoplasms|Cholestasis May 2015 Phase 1
NCT02092363 OncoMed Pharmaceuticals, Inc. Ovarian Cancer January 2014 Phase 1
NCT00670436 University of Ulm|B. Braun Melsungen AG Coronary Artery Disease|Chronic Total Occlusion|Native Coronary Artery February 2008 Phase 2
NCT00502203 M.D. Anderson Cancer Center Mixed Tumor, Mullerian August 2001 Phase 2
NCT02593175 M.D. Anderson Cancer Center|Amgen Breast Cancer August 2016 Phase 2
NCT00511849 Pfizer Neoplasms November 2005 Phase 1
NCT00020761 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer April 2000 Phase 2
NCT01108055 Sandy Srinivas|GlaxoSmithKline|Stanford University Bladder Cancer|Bladder (Urothelial, Transitional Cell) Cancer|Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)|Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)|Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable April 2010 Phase 2
NCT01739894 National University Hospital, Singapore Gastric Cancer January 2013 Phase 2
NCT02187991 US Oncology Research|Millennium Pharmaceuticals, Inc. Breast Cancer|Breast Carcinoma|Breast Tumors|Malignant Neoplasm of Breast February 2015 Phase 2
NCT01326767 Central European Society for Anticancer Drug Research|Saladax Biomedical, Inc.|Cantonal Hospital of St. Gallen|University Hospital, Basel, Switzerland|Assign Data Management and Biostatistics GmbH|Wake Forest University|University Hospital, Essen Carcinoma, Non-Small-Cell Lung March 2011 Phase 3
NCT01023204 Bristol-Myers Squibb Breast Cancer October 2002 Phase 2
NCT00768469 Puma Biotechnology, Inc. Advanced Malignant Solid Tumors October 2008 Phase 1
NCT00738361 Ohio State University Comprehensive Cancer Center|National Comprehensive Cancer Network|Celgene Corporation Intraocular Melanoma August 2008 Phase 2
NCT01572727 Novartis Pharmaceuticals|Novartis Breast Cancer August 2012 Phase 2|Phase 3
NCT00881101 Nanjing Sike Pharmaceutical Co., Ltd. Solid Tumor April 2009 Phase 1
NCT00971945 Bristol-Myers Squibb Breast Cancer June 2005 Phase 2
NCT00971867 Bristol-Myers Squibb Head and Neck Cancer August 2006 Phase 2
NCT02391662 Asociación de Oncología Médica del Hospital de Cruces Pancreatic Carcinoma Metastatic May 2015 Phase 2
NCT01024062 Bristol-Myers Squibb Non-Small Cell Lung Cancer December 2002 Phase 2
NCT01647828 OncoMed Pharmaceuticals, Inc. Stage IV Pancreatic Cancer October 2012 Phase 1|Phase 2
NCT00313768 Pfizer Carcinoma, Non-Small-Cell Lung December 2005 Phase 2
NCT02207361 Tianjin Medical University Cancer Institute and Hospital Metastatic Breast Cancer December 2013 Phase 4
NCT01000896 AstraZeneca Cancer|Non Small Cell Lung Cancer|Epithelial Ovarian Cancer January 2010 Phase 1
NCT01495247 Novartis Pharmaceuticals|Novartis Inoperable Locally Advanced Breast Cancer|Metastatic Breast Cancer (MBC) January 2012 Phase 1|Phase 2
NCT02756013 Case Comprehensive Cancer Center Gynecologic Malignancies April 2016 Phase 2
NCT01024101 Bristol-Myers Squibb Head and Neck Cancer January 2004 Phase 2
NCT00855764 Bristol-Myers Squibb Head and Neck Cancer October 2005 Phase 2
NCT02133612 Chinese Academy of Medical Sciences Esophageal Cancer December 2007 Phase 2
NCT01248403 Krankenhaus Nordwest Advanced Gastric Cancer|Esophagogastric Junction Cancer October 2011 Phase 3
NCT01196234 Asan Medical Center|AstraZeneca Non Small Cell Lung Cancer December 2009 Phase 2
NCT00823186 Chang Gung Memorial Hospital|Sinphar Pharmaceutical Co., Ltd Cervical Cancer February 2009 Phase 1
NCT00626561 M.D. Anderson Cancer Center|Genentech, Inc. Cervical Cancer|Uterine Cancer February 2008 Phase 2
NCT00971841 Bristol-Myers Squibb Esophageal Cancer March 2008 Phase 2
NCT01276041 Memorial Sloan Kettering Cancer Center|Genentech, Inc.|University of Pennsylvania Breast Cancer January 2011 Phase 2
NCT01868984 Englewood Hospital and Medical Center|Spectranetics Corporation Fistula Stenosis May 2013 Phase 2
NCT02923739 M.D. Anderson Cancer Center|Genentech, Inc. Malignant Neoplasms of Female Genital Organs May 5, 2017 Phase 2
NCT01980277 Institut Paoli-Calmettes Breast Cancer January 2014 Phase 1|Phase 2
NCT01014351 SCRI Development Innovations, LLC|Novartis Metastatic Melanoma February 2010 Phase 2
NCT00034541 ImClone LLC|University of Colorado, Denver|Greenwich Hospital|IUPUI, Indianapolis, IN Carcinoma, Non-Small-Cell Lung December 2000 Phase 1|Phase 2
NCT00556088 SCRI Development Innovations, LLC|Novartis Solid Tumors December 2007 Phase 1
NCT02432365 Chang Gung Memorial Hospital|Asian Gynecologic Oncology Group|Taiwanese Gynecologic Oncology Group Cervical Cancer February 2015 Phase 2
NCT02340117 SynerGene Therapeutics, Inc. Metastatic Pancreatic Cancer January 2015 Phase 2
NCT01484080 Centro Nacional de Investigaciones Oncologicas CARLOS III|Hospital Universitario de Fuenlabrada|M.D. Anderson Cancer Center|Hospital Universitari de Bellvitge|Grupo Espanol de Investigacion del Cancer de Mama Breast Cancer October 2011 Phase 1|Phase 2
NCT03083613 Chinese Academy of Medical Sciences Gastric Cancer|Gastroesophageal Junction Adenocarcinoma May 2015 Phase 2
NCT00006227 Gynecologic Oncology Group|National Cancer Institute (NCI) Adult Type Ovarian Granulosa Cell Tumor|Ovarian Gynandroblastoma|Ovarian Sertoli-Leydig Cell Tumor|Ovarian Sex Cord Tumor With Annular Tubules|Ovarian Steroid Cell Tumor November 2000 Phase 2
NCT01621243 Momenta Pharmaceuticals, Inc. Metastatic Pancreatic Cancer May 2012 Phase 1|Phase 2
NCT01839773 Daehwa Pharmaceutical Co., Ltd. Stage IV Gastric Cancer March 2013 Phase 3
NCT02436993 University of California, Irvine Breast Carcinoma April 2015 Phase 2
NCT00465907 Sidney Kimmel Comprehensive Cancer Center Lung Cancer May 2003 Phase 2
NCT02628132 King Faisal Specialist Hospital & Research Center|AstraZeneca Breast Cancer July 2016 Phase 1|Phase 2
NCT00544648 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer November 2007 Phase 1|Phase 2
NCT02138812 Bayer Medical Oncology May 9, 2014 Phase 1
NCT00686322 Taipei Veterans General Hospital, Taiwan Non-small-cell Lung Cancer April 2008 Phase 4
NCT00532857 Jungsil Ro|National Cancer Center, Korea Breast Cancer March 2007 Phase 2
NCT02423603 Queen Mary University of London|AstraZeneca|Cancer Research UK Metastatic Breast Cancer May 2014 Phase 2
NCT01224652 Korean Cancer Study Group|Boryung Pharmaceutical Co., Ltd Gastric Cancer Phase 3
NCT03121352 Case Comprehensive Cancer Center Metastatic Triple Negative Breast Cancer May 19, 2017 Phase 2
NCT01447706 Merrimack Pharmaceuticals|Sanofi Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer October 2011 Phase 2
NCT02300935 SCRI Development Innovations, LLC|Celgene Corporation|GlaxoSmithKline Melanoma January 2016 Phase 1
NCT01407562 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey|GlaxoSmithKline Unspecified Adult Solid Tumor - Protocol Specific|Breast Cancer - Female August 2011 Phase 1
NCT01548924 Centro Nacional de Investigaciones Oncologicas CARLOS III|Hospital Universitario de Fuenlabrada|M.D. Anderson Cancer Center|Hospital Universitari de Bellvitge Solid Tumors April 2012 Phase 1
NCT00983424 Northwestern University|Avon Foundation Metastatic Breast Cancer February 2010 Phase 1
NCT02301143 Celgene Pancreatic Neoplasms April 2015 Phase 2
NCT00088829 Georgetown University|National Cancer Institute (NCI) Breast Cancer April 2001 Phase 2
NCT01088815 Sidney Kimmel Comprehensive Cancer Center|Stand Up To Cancer|Genentech, Inc.|Celgene Corporation Metastatic Pancreatic Cancer September 2010 Phase 2
NCT01565499 Spanish Breast Cancer Research Group|Celgene Corporation Breast Cancer June 2013 Phase 2
NCT02040454 Englewood Hospital and Medical Center Arteriovenous Access Fistula Stenosis March 2014 Phase 2
NCT01962948 Fox Chase Cancer Center|National Cancer Institute (NCI) Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer October 9, 2013 Phase 1|Phase 2
NCT00662311 University of Washington|National Cancer Institute (NCI) Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer March 2008 Phase 1|Phase 2
NCT02058433 Caicun Zhou|Tongji University Non-Small Cell Lung Cancer January 2014 Phase 3
NCT01325441 Boston Biomedical, Inc Cancer April 2011 Phase 1|Phase 2
NCT02240212 Novartis Pharmaceuticals|Novartis Cancer October 2014 Phase 1
NCT02672475 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma March 2016 Phase 1
NCT00756847 Sanofi Cancer|Non-Small Cell Lung Cancer|Endometrial Carcinoma|Ovarian Carcinoma September 2008 Phase 1
NCT02152137 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Daiichi Sankyo Inc. Anaplastic Thyroid Cancer|Recurrent Thyroid Cancer September 2014 Phase 2
NCT01756183 Zhejiang Cancer Hospital Surgically-Created Resection Cavity|Drug Safety September 2011 Phase 2
NCT00085358 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Carcinosarcoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer May 2004 Phase 1
NCT02474173 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage III Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma January 15, 2016 Phase 1
NCT00030368 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 2001 Phase 1
NCT02174887 Institut Paoli-Calmettes Pancreatic Adenocarcinoma September 2014 Phase 1
NCT00542451 Eric Winer, MD|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Genentech, Inc.|Dana-Farber Cancer Institute Breast Cancer|Carcinoma of the Breast October 2007 Phase 2
NCT02001974 Dompé Farmaceutici S.p.A|PRA Health Sciences Metastatic Breast Cancer January 2012 Phase 1
NCT02993731 Boston Biomedical, Inc Carcinoma, Pancreatic Ductal December 2016 Phase 3
NCT01200342 M.D. Anderson Cancer Center|Genta Incorporated Melanoma December 2010 Phase 2
NCT02564146 AIO-Studien-gGmbH|ClinAssess GmbH|Celgene Corporation Metastatic Pancreatic Cancer|Adenocarcinoma of the Pancreas December 2016 Phase 2
NCT00660218 State University of New York - Upstate Medical University|CTI BioPharma Carcinoma, Squamous Cell March 2008 Phase 1|Phase 2
NCT00003092 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 1997 Phase 3
NCT01770301 ARCAGY/ GINECO GROUP|Roche Pharma AG Ovarian Sex-cord Stromal Tumor February 2013 Phase 2
NCT00499252 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma June 2007 Phase 2
NCT00814086 Gynecologic Oncology Group|National Cancer Institute (NCI) Chemotherapeutic Agent Toxicity|Endometrial Adenocarcinoma|Fallopian Tube Carcinoma|Gastrointestinal Complication|Malignant Ovarian Mixed Epithelial Tumor|Neurotoxicity Syndrome|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Primary Peritoneal Carcinoma|Stage II Ovarian Cancer|Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Undifferentiated Ovarian Carcinoma February 2009 Phase 1
NCT01700010 University of Michigan Cancer Center|GlaxoSmithKline Urothelial Cancer|Bladder Cancer November 2012 Phase 2
NCT01416558 German Breast Group Metastatic Breast Cancer July 2011 Phase 2
NCT01746771 Hanmi Pharmaceutical Company Limited|National OncoVenture HER-2 Positive Advanced Gastric Cancer November 2012 Phase 1|Phase 2
NCT01297452 Memorial Sloan Kettering Cancer Center|Novartis Pharmaceuticals|Sai Life Sciences Solid Tumors February 15, 2011 Phase 1
NCT02350517 Yuhong Li|Sun Yat-sen University Esophageal Squamous Cell Carcinoma January 2015 Phase 2
NCT02425891 Hoffmann-La Roche Triple Negative Breast Cancer June 23, 2015 Phase 3
NCT02834975 Marilyn Huang|Merck Sharp & Dohme Corp.|University of Miami Fallopian Tube Carcinoma|Peritoneal Carcinoma|Epithelial Ovarian Cancer December 22, 2016 Phase 2
NCT00096343 University of Alabama at Birmingham|National Cancer Institute (NCI) Breast Cancer October 2002 Phase 2
NCT00881816 Nanjing Sike Pharmaceutical Co., Ltd. Advanced Gastric Carcinoma April 2009 Phase 1
NCT00057863 National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVA Cervical Cancer|Stage IVB Cervical Cancer January 2003 Phase 2
NCT01097746 M.D. Anderson Cancer Center|Genentech, Inc. Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer April 2010 Phase 2
NCT00356811 GlaxoSmithKline Neoplasms, Breast May 2006 Phase 2
NCT01421472 Merrimack Pharmaceuticals|Sanofi ER Positive, Her2 Negative Breast Cancer Patients|Triple Negative Breast Cancer Patients August 2011 Phase 2
NCT00100139 INSYS Therapeutics Inc Neoplasm November 2004 Phase 1
NCT00003130 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 1997 Phase 2
NCT01934634 US Oncology Research|Novartis Pharmaceuticals|Delta Clinical Research, LLC Metastatic Pancreatic Cancer March 2014 Phase 1
NCT00079430 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Primary Peritoneal Cavity Cancer|Stage II Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer June 2004 Phase 1
NCT01964430 Celgene Pancreatic Neoplasms|Digestive System Neoplasms|Neoplasms by Site|Neoplasms|Endocrine Gland Neoplasms|Pancreatic Diseases|Digestive System Diseases|Endocrine System Diseases|Gemcitabine|Antimetabolites, Antineoplastic March 1, 2014 Phase 3
NCT00300885 Bayer Carcinoma, Non-Small Cell Lung February 2006 Phase 3
NCT00075270 GlaxoSmithKline Neoplasms, Breast January 2004 Phase 3
NCT00486954 GlaxoSmithKline Neoplasms, Gastrointestinal Tract July 2007 Phase 3
NCT01494688 Hoffmann-La Roche Advanced Solid Tumors December 2011 Phase 1
NCT00217607 UNICANCER Sarcoma February 2005 Phase 2
NCT00866528 GlaxoSmithKline Lung Cancer, Non-Small Cell July 2009 Phase 1
NCT01161186 University of California, San Francisco|Celgene Corporation Pancreatic Neoplasms|Pancreatic Cancer|Adenocarcinoma July 2010 Phase 1
NCT00005646 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer April 2000 Phase 2
NCT03051373 Chinese PLA General Hospital Carcinoma, Transitional Cell April 1, 2017 Phase 2
NCT01599078 Midwest Cardiovascular Research Foundation|Spectranetics Corporation Restenosis|Peripheral Arterial Disease January 2012
NCT00003120 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer November 1997 Phase 3
NCT02615730 Yonsei University Advanced Gastric Adenocarcinoma February 2016 Phase 1|Phase 2
NCT00653952 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sequus Pharmaceuticals|ALZA Ovarian Neoplasms May 1997 Phase 3
NCT01263145 National Cancer Institute (NCI) Adult Solid Neoplasm|Recurrent Breast Carcinoma|Stage IV Breast Cancer January 5, 2011 Phase 1
NCT02945800 H. Lee Moffitt Cancer Center and Research Institute|National Pediatric Cancer Foundation Osteosarcoma|Ewing Sarcoma|Rhabdomyosarcoma|Soft Tissue Sarcoma October 21, 2016 Phase 2
NCT02077881 NewLink Genetics Corporation Metastatic Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer August 2014 Phase 1|Phase 2
NCT00010257 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Thymoma|Thymic Carcinoma February 2001 Phase 2
NCT00453167 National Cancer Center, Korea Lung Cancer December 2005 Phase 2
NCT00540514 Celgene Non-Small Cell Lung Carcinoma November 2007 Phase 3
NCT02382263 PH Research, S.L. Advanced Pancreatic Cancer April 2013 Phase 1|Phase 2
NCT00031694 National Cancer Institute (NCI) Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer January 2002 Phase 2
NCT01704690 Peking University Esophageal Cancer August 2012 Phase 2|Phase 3
NCT00358163 Massachusetts General Hospital|Novartis Pharmaceuticals|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Dana-Farber Cancer Institute Metastatic Non-hematologic Malignancies April 2006 Phase 1
NCT02513563 H. Lee Moffitt Cancer Center and Research Institute Lung Cancer September 8, 2015 Phase 2
NCT02569489 HUYA Bioscience International Breast Cancer December 2015 Phase 1
NCT01423695 WiSP Wissenschaftlicher Service Pharma GmbH|Bristol-Myers Squibb|Roche Pharma AG Metastatic Breast Cancer February 2001 Phase 2
NCT01199055 Daiichi Sankyo Co., Ltd.|ICON Clinical Research|Daiichi Sankyo Inc. Carcinoma, Non-Small-Cell Lung March 2010 Phase 1
NCT02396108 National University Hospital, Singapore Breast Cancer March 2015 Phase 1|Phase 2
NCT02379247 University of Kansas Medical Center|Novartis Pharmaceuticals Breast Cancer February 2015 Phase 1|Phase 2
NCT02366949 Bayer Medical Oncology February 27, 2015 Phase 1
NCT02826161 Boston Biomedical, Inc Carcinoma, Non-Small-Cell Lung November 2016 Phase 3
NCT02630199 Samsung Medical Center Refractory Cancer December 2015 Phase 1
NCT00059787 National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer April 2003 Phase 2
NCT02312661 University Medical Center Groningen Epithelial Ovarian Cancer October 2015 Phase 1
NCT01525602 Plexxikon Solid Tumors May 2012 Phase 1
NCT02783222 Fondazione Sandro Pitigliani Breast Cancer November 2012 Phase 2
NCT01235897 University of California, San Francisco|Merck Sharp & Dohme Corp. Advanced Solid Tumors|Tumors|Cancer March 2011 Phase 1
NCT00544232 German Breast Group|Pharmacia|Amgen|Bristol-Myers Squibb Breast Cancer August 2002 Phase 3
NCT02392637 M.D. Anderson Cancer Center|Celgene Biliary Tract Cancer April 2015 Phase 2
NCT01411410 Bayer Neoplasms August 2011 Phase 1
NCT02501603 Yonsei University Gastric Cancer|Gastroesophageal Junction Cancer July 2016 Phase 2
NCT02392507 Eli Lilly and Company|Celgene Carcinoma, Non-small-Cell Lung October 2015 Phase 2
NCT02440425 H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme Corp. Ovarian Cancer August 12, 2015 Phase 2
NCT02060253 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Synta Pharmaceuticals Corp.|New York University Cancer Institute HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer April 2014 Phase 1
NCT02689427 M.D. Anderson Cancer Center|Astellas Pharma US, Inc. Breast Cancer September 2016 Phase 2
NCT01851174 Western Regional Medical Center Pancreatic Carcinoma Non-resectable|Stage IV Pancreatic Cancer February 2013 Phase 2
NCT01705483 Astellas Pharma Global Development, Inc.|Astellas Pharma Inc Pharmacokinetics of ASP9853|Non-hematologic Malignancies August 2012 Phase 1
NCT00152477 UCB Pharma Carcinoma|Non-Squamous Non-Small-Cell Lung Cancer August 2005 Phase 2
NCT00353717 Hadassah Medical Organization Breast Neoplasms November 2006 Phase 1|Phase 2
NCT02069158 Cristiana Sessa|Oncology Institute of Southern Switzerland Breast Cancer|NSCLC|Ovary Cancer|Endometrial Cancer|Small Cell Lung Cancer (SCLC)|Head and Neck (HNSCC) April 2014 Phase 1
NCT00991796 Daiichi Sankyo Inc. Non-small Cell Lung Cancer June 2009 Phase 2
NCT01722968 Theodoros Foukakis|Karolinska University Hospital Breast Cancer November 2012 Phase 2
NCT00888615 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Tumor|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recu December 2010 Phase 2
NCT01852292 Novartis Pharmaceuticals|Novartis Head and Neck Squamous Cell Carcinoma October 1, 2013 Phase 2
NCT00337532 Bristol-Myers Squibb Head and Neck Cancer May 2005 Phase 2|Phase 3
NCT01174238 Adil Daud|University of California, San Francisco Melanoma July 2010 Phase 2
NCT00937560 Hoffmann-La Roche Ovarian Cancer June 2009 Phase 2
NCT02753998 Assistance Publique - Hôpitaux de Paris|Bard Peripheral Vascular (balloons provider) Angioplasty|Stenosis of Arteriovenous Fistula December 2016 Phase 3
NCT02924909 Instituto Nacional de Cancer, Brazil Esophageal Cancer|Induction Chemotherapy November 2016 Phase 2
NCT00753909 Hellenic Oncology Research Group Non Small Cell Lung Cancer November 2008 Phase 2
NCT02276560 UNC Lineberger Comprehensive Cancer Center Stage IIIA Non-Small Cell Lung Cancer January 2015 Phase 2
NCT00231868 Montefiore Medical Center Uterine Cancer December 2001 Phase 2
NCT00507429 Mateon Therapeutics Anaplastic Thyroid Cancer August 2007 Phase 2|Phase 3
NCT00603941 Daiichi Sankyo Inc. Anaplastic Thyroid Cancer January 2008 Phase 1|Phase 2
NCT02163694 AbbVie Metastatic Breast Cancer July 2014 Phase 3
NCT01858883 Incyte Corporation Metastatic Cancer|Metastatic Pancreatic Cancer June 2013 Phase 1|Phase 2
NCT02716038 Columbia University|Genentech, Inc.|Celgene Corporation Carcinoma, Non-Small-Cell Lung June 7, 2016 Phase 2
NCT01493310 University of Chicago Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer November 2011 Phase 1
NCT01677559 Washington University School of Medicine Adenocarcinoma|Pancreatic Neoplasms May 7, 2013 Phase 1
NCT00887575 SCRI Development Innovations, LLC|Pfizer Breast Cancer June 2009 Phase 1|Phase 2
NCT03193853 Baylor Research Institute|Takeda Triple Negative Breast Cancer July 5, 2017 Phase 2
NCT01351350 Millennium Pharmaceuticals, Inc. Advanced Solid Malignancies|Hematologic Malignancies March 2011 Phase 1
NCT00873119 Onxeo|Spectrum Pharmaceuticals, Inc Carcinoma of Unknown Primary February 2009 Phase 2
NCT01055028 Stanford University|Genentech, Inc. Angiosarcomas|Soft Tissue Sarcoma February 2010 Phase 2
NCT00825201 City of Hope Medical Center|National Cancer Institute (NCI)|National Comprehensive Cancer Network Ovarian Cancer|Peritoneal Cavity Cancer|Unspecified Adult Solid Tumor, Protocol Specific January 2009 Phase 1
NCT00635050 University of Alabama at Birmingham|Ortho Biotech, Inc.|Genentech, Inc. Invasive Breast Cancer March 2008 Phase 2
NCT00558636 Bayer Carcinoma, Non-Small-Cell Lung September 2007 Phase 3
NCT00096291 Massachusetts General Hospital|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 2
NCT00006018 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 2000 Phase 1
NCT02824575 Montefiore Medical Center|Deciphera Pharmaceuticals LLC|Albert Einstein College of Medicine, Inc. Breast Cancer|Breast Adenocarcinoma|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Recurrent Breast Carcinoma|Stage IV Breast Cancer July 2016 Phase 1
NCT02050178 OncoMed Pharmaceuticals, Inc. Pancreatic Cancer|Stage IV Pancreatic Cancer November 2013 Phase 1
NCT01745367 AVEO Pharmaceuticals, Inc.|Astellas Pharma Inc Triple Negative Breast Cancer November 2012 Phase 2
NCT02827201 Federation Francophone de Cancerologie Digestive|UNICANCER|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Metastatic Pancreatic Cancer November 2015 Phase 2
NCT01160601 Peregrine Pharmaceuticals Non-Squamous Non-Small Cell Lung Cancer June 2010 Phase 2
NCT02881125 University of Washington|National Cancer Institute (NCI) Small Cell Carcinoma November 2016 Phase 1
NCT02861690 Sun Yat-sen University Esophageal Carcinoma January 2010 Phase 2
NCT01220154 David O'Malley|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|No Prior Chemotherapy October 2010 Phase 1
NCT00561119 Samsung Medical Center|Korean Cancer Study Group Advanced Breast Cancer May 2007 Phase 3
NCT01264328 Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Amgen|Trial Form Support S.L. Head and Neck Cancer December 2010 Phase 2
NCT00313599 University of California, San Francisco|National Cancer Institute (NCI) Bladder Cancer|Brain and Central Nervous System Tumors|Breast Cancer|Esophageal Cancer|Extragonadal Germ Cell Tumor|Gastric Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer February 2006 Phase 1
NCT00002913 National Cancer Institute (NCI) Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer December 1996 Phase 1
NCT01007578 Bayer Peripheral Arterial Disease|Stenotic Femoro-popliteal Arteries|Occluded Femoro-popliteal Arteries|Atherosclerosis September 2007 Phase 1
NCT02308553 Prof. Dr. med. Dirk Schadendorf|Boehringer Ingelheim|medac GmbH|Alcedis GmbH|University Hospital, Essen Cutaneous Malignant Melanoma January 2015 Phase 1|Phase 2
NCT01249443 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation|University of Arkansas HIV Infection|Recurrent Anal Cancer|Recurrent Breast Cancer|Recurrent Esophageal Cancer|Recurrent Gastric Cancer|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recur November 2013 Phase 1
NCT02525653 Memorial Sloan Kettering Cancer Center|Celgene Corporation|Miami Cancer Institute Lung Cancer|Untreated Stage IV or Recurrent Squamous Cell Lung Cancers August 2015 Phase 2
NCT00728845 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Lung Cancer June 16, 2008 Phase 1|Phase 2
NCT01433614 Thomas Hatschek|Karolinska University Hospital Metastatic Breast Cancer December 2002 Phase 3
NCT01120158 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer September 2009 Phase 2
NCT02632305 AHS Cancer Control Alberta|Celgene Unresectable Biliary Tract Cancer July 2016 Phase 2
NCT00702299 University of Arizona|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer September 2007 Phase 1
NCT00317200 Hoosier Cancer Research Network|Genentech, Inc.|Walther Cancer Institute Small Cell Lung Cancer April 2006 Phase 2
NCT00629499 SCRI Development Innovations, LLC|Celgene Corporation Breast Cancer April 2008 Phase 2
NCT00022633 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer July 2001 Phase 2
NCT01223443 Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec|Boston Scientific Corporation|Canadian Institutes of Health Research (CIHR) Coronary Artery Bypass Grafting April 2010 Phase 4
NCT01236716 Chinese Society of Lung Cancer Carcinoma, Non-Small-Cell Lung November 2010 Phase 2
NCT00588237 Memorial Sloan Kettering Cancer Center|Genentech, Inc. Ovarian Cancer|Primary PERITONEUM|Fallopian Tube Cancer August 2006 Phase 2
NCT01625286 AstraZeneca Advanced or Metastatic Breast Cancer|ER+ve Advanced or Metastatic Breast Cancer October 3, 2012 Phase 1|Phase 2
NCT01924533 AstraZeneca Gastric Cancer September 2013 Phase 3
NCT02767557 Herlev Hospital|Celgene Unresectable Pancreatic Carcinoma January 26, 2017 Phase 2
NCT00154726 National Taiwan University Hospital Locally Advanced and Recurrent/Metastatic Gastric Cancer April 1997 Phase 2
NCT02283372 Washington University School of Medicine Pancreatic Cancer January 21, 2015 Phase 1
NCT02891018 Shandong Branden Med.Device Co.,Ltd|Fudan University In-stent Restenosis December 2015 Phase 3
NCT00062010 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lung Cancer February 2004 Phase 2
NCT00617370 Memorial Sloan Kettering Cancer Center|Amgen|Pfizer Breast Cancer|Adenocarcinoma of the Breast November 2004
NCT02311907 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Chemotherapeutic Agent Toxicity|Neuropathy|Neurotoxicity Syndrome|Pain|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer December 2009 Phase 3
NCT01728441 Provascular GmbH|William Cook Europe Peripheral Artery Disease October 2012
NCT02911350 New York University School of Medicine Prostate Cancer May 2000 Phase 1
NCT02799862 iOMEDICO AG|Celgene Corporation Carcinoma, Non-Small-Cell Lung August 2016
NCT00178256 University of Rochester Carcinoma, Non-Small-Cell Lung June 1998 Phase 1|Phase 2
NCT00687817 Peregrine Pharmaceuticals Non-small Cell Lung Cancer June 2008 Phase 2
NCT02999477 Dana-Farber Cancer Institute|Merck Sharp & Dohme Corp. Breast Cancer February 23, 2017 Phase 2
NCT01138046 GlaxoSmithKline Neoplasms, Breast April 2010 Phase 2
NCT02016287 Shen Lin|Peking University Esophageal Squamous Cell Cancer|Elderly Patients December 2013 Phase 2
NCT01034189 National Taiwan University Hospital Esophageal Cancer October 2008 Phase 2
NCT00238420 National Cancer Institute (NCI) Bladder Urothelial Carcinoma|Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer July 2005 Phase 1|Phase 2
NCT01136031 Seoul National University Hospital Advanced Gastric Cancer January 2008 Phase 1|Phase 2
NCT02370238 Dompé Farmaceutici S.p.A|PRA Health Sciences Metastatic Breast Cancer June 2015 Phase 2
NCT01839890 Francisco Javier Goicolea|Effice Servicios Para la Investigacion S.L.|Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular Acute Myocardial Infarction April 2012 Phase 3
NCT02651727 Verastem, Inc. Pancreatic Cancer September 2015 Phase 1
NCT01336062 Peking University Gastric Adenocarcinoma April 2011 Phase 1|Phase 2
NCT01146795 Jason D. Wright|Genentech, Inc.|Columbia University Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer May 2010 Phase 2
NCT01255956 Medical University of Warsaw|KCRI In-Stent Restenosis December 2010 Phase 3
NCT01402271 European Organisation for Research and Treatment of Cancer - EORTC Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer July 2012 Phase 1|Phase 2
NCT03048942 University Hospitals Bristol NHS Foundation Trust HER2 Negative Metastatic Breast Cancer November 2014 Phase 2
NCT02614833 Immutep S.A.|Prima BioMed Ltd Adenocarcinoma Breast Stage IV December 2015 Phase 2
NCT02976909 Yuhong Li|Sun Yat-sen University Esophageal Squamous Cell Carcinoma November 2016 Phase 2
NCT02698891 Dana-Farber Cancer Institute Early Stage Breast Cancer April 2016 Phase 2
NCT00513786 David O'Malley|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Endometrial Cancer August 2007 Phase 2
NCT01367002 Yale University|Genentech, Inc. Endometrial Cancer June 2011 Phase 2
NCT00494182 M.D. Anderson Cancer Center|Bayer Head and Neck Cancer|Squamous Cell Carcinoma April 2007 Phase 2
NCT01057342 Swiss Group for Clinical Cancer Research Lung Cancer January 2010 Phase 2
NCT01485848 Esperance Pharmaceuticals Inc Ovarian Cancer Recurrent February 2012 Phase 2
NCT02758847 University of Pittsburgh Ischemia September 2016
NCT02559674 Altor Bioscience Corporation Advanced Pancreatic Cancer July 2016 Phase 1|Phase 2
NCT00251095 OncoGenex Technologies Breast Neoplasm September 2005 Phase 3
NCT03064126 Boston Scientific Corporation Peripheral Artery Disease|Atherosclerosis|Artery Diseases, Peripheral|Plaque, Atherosclerotic|Occlusive Arterial Disease March 2, 2017 Phase 3
NCT00491855 M.D. Anderson Cancer Center Peritoneal Cancer June 2007 Phase 1
NCT00054028 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer December 2002 Phase 1|Phase 2
NCT00062179 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Pharmacia Lung Cancer March 2003 Phase 2
NCT01199263 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma December 6, 2010 Phase 2
NCT01834235 Precision Biologics, Inc Pancreatic Cancer, Adult April 2013 Phase 1|Phase 2
NCT01625429 Shanghai Cancer Hospital, China Breast Cancer June 2012 Phase 2
NCT02608229 Washington University School of Medicine|BioMed Valley Discoveries, Inc Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer June 6, 2016 Phase 1
NCT01276769 Chinese Academy of Medical Sciences Triple Negative Breast Cancer January 2008 Phase 2
NCT02043730 Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente|Unità Sperimentazioni cliniche|Istituto Nazionale Tumori di Napoli Pancreatic Cancer Stage II January 2014 Phase 2
NCT01893801 Gayle Jameson|Translational Genomics Research Institute|Translational Drug Development|Virgina G. Piper Cancer Center - Clinical Trials|Pancreatic Cancer Research Team Stage IV Pancreatic Cancer May 2013 Phase 1|Phase 2
NCT00398086 Celgene Corporation Metastatic Pancreatic Cancer November 2006 Phase 1|Phase 2
NCT00028990 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|NCIC Clinical Trials Group|NSABP Foundation Inc Breast Cancer December 2001 Phase 3
NCT02124707 UNC Lineberger Comprehensive Cancer Center Head and Neck Cancer|Squamous Cell Carcinoma of the Head and Neck April 2014 Phase 2
NCT02514551 Eli Lilly and Company Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma October 2015 Phase 2
NCT01646762 Mayo Clinic|National Cancer Institute (NCI) Refractory Plasma Cell Myeloma November 2012 Phase 2
NCT02540018 Jena University Hospital|iVascular S.L.U.|KKS Netzwerk Peripheral Arterial Disease September 2015
NCT01525966 City of Hope Medical Center|National Cancer Institute (NCI) Inflammatory Breast Cancer|Stage IIA Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer|Stage IIB Breast Cancer|Estrogen Receptor Negative|Progesterone Receptor Negative|HER2/Neu Negative February 15, 2012 Phase 2
NCT01579578 AstraZeneca Metastatic, Gastric or Gastro-oesophageal Junction, Cancer April 2012 Phase 2
NCT02341456 AstraZeneca Advanced Solid Tumours January 16, 2015 Phase 1
NCT00110084 Mayo Clinic|National Cancer Institute (NCI) Breast Cancer August 2005 Phase 2
NCT02038647 Millennium Pharmaceuticals, Inc.|Takeda Small Cell Lung Cancer (SCLC) February 2014 Phase 2
NCT00707707 AstraZeneca Breast Cancer|Triple Negative Breast Cancer|Metastatic Breast Cancer September 15, 2008 Phase 1
NCT02047513 AIO-Studien-gGmbH|Celgene|ClinAssess GmbH Resectable Pancreatic Cancer|Ductal Adenocarcinoma of the Pancreas April 2015 Phase 2
NCT00100789 Southwest Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer January 2005 Phase 2
NCT01295502 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Stage IB Cervical Cancer|Stage IIA Cervical Cancer|Stage IIB Cervical Cancer|Stage IIIA Cervical Cancer|Stage IIIB Cervical Cancer|Stage IVA Cervical Cancer April 2011 Phase 1
NCT01256762 Geron Corporation Locally Recurrent or Metastatic Breast Cancer November 2010 Phase 2
NCT00174434 Pfizer Breast Neoplasms September 2005 Phase 1
NCT01170663 Eli Lilly and Company Gastric Cancer December 2010 Phase 3
NCT02586753 Mianyang Central Hospital Esophageal Squamous Cell Carcinoma December 2015 Phase 2
NCT02891005 Shandong Branden Med.Device Co.,Ltd Small Vessel Lesion December 2015 Phase 3
NCT02016274 Shen Lin|Peking University Esophageal Squamous Cell Cancer December 2013 Phase 2
NCT00702572 Milton S. Hershey Medical Center Non-small Cell Lung Cancer April 2008 Phase 1
NCT02929576 Medivation, Inc.|Astellas Pharma Inc Breast Cancer September 2016 Phase 3
NCT00003644 Gynecologic Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group Ovarian Cancer October 1998 Phase 3
NCT02301988 Genentech, Inc.|SOLTI Breast Cancer Research Group Breast Cancer February 17, 2015 Phase 2
NCT01366144 National Cancer Institute (NCI)|Abbott Breast Carcinoma|Carcinoma of Unknown Primary Origin|Endometrial Carcinoma|Esophageal Carcinoma|Lung Carcinoma|Malignant Head and Neck Neoplasm|Melanoma|Ovarian Carcinoma|Renal Pelvis and Ureter Urothelial Carcinoma|Testicular Lymphoma June 20, 2011 Phase 1
NCT03125902 Hoffmann-La Roche Triple-Negative Breast Cancer August 3, 2017 Phase 3
NCT01042925 Sanofi Breast Cancer|Breast Neoplasms February 2010 Phase 1|Phase 2
NCT02109341 Gruppo Oncologico Italiano di Ricerca Clinica Metastatic Pancreatic Cancer February 2014 Phase 1|Phase 2
NCT00683059 Sunnybrook Health Sciences Centre|Celgene Corporation Transitional Cell Carcinoma March 2008 Phase 2
NCT01238133 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma December 2010 Phase 1
NCT02467907 Hoffmann-La Roche Cervical Cancer July 28, 2015 Phase 2
NCT02581982 Wake Forest University Health Sciences|National Cancer Institute (NCI) Transitional Cell Carcinoma March 2016 Phase 2
NCT02162719 Genentech, Inc. Breast Neoplasms September 2014 Phase 2
NCT03116152 Innovent Biologics (Suzhou) Co. Ltd. Efficacy and Safety April 2017 Phase 2
NCT01971281 NovoCure Ltd. Pancreatic Adenocarcinoma November 2013 Phase 1|Phase 2
NCT01616888 University Health Network, Toronto In-stent Arterial Restenosis June 2012
NCT01558492 Weill Medical College of Cornell University Prostate Cancer March 2011 Phase 2
NCT02640053 Academic and Community Cancer Research United|National Cancer Institute (NCI) Breast Carcinoma December 2015
NCT02367352 Millennium Pharmaceuticals, Inc.|Takeda Advanced Solid Tumors|Ovarian Cancer|Small Cell Lung Cancer March 25, 2015 Phase 1
NCT01821833 New Mexico Cancer Care Alliance|Alliance Healthcare Foundation Breast Cancer|Ovarian Neoplasm|Pain February 2013
NCT02437812 Gynecologic Oncology Associates|University of North Carolina, Chapel Hill Epithelial Ovarian Carcinoma January 2014 Phase 2
NCT01463072 City of Hope Medical Center|National Cancer Institute (NCI) Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer June 2012 Phase 2
NCT01268059 MedImmune LLC Non-small Cell Lung Cancer December 2010 Phase 1|Phase 2
NCT00390611 SCRI Development Innovations, LLC|Bayer Ovarian Cancer October 2006 Phase 2
NCT02996318 University Hospital, Saarland|InnoRa GmbH DES In-stent Stenosis May 2016 Phase 2|Phase 3
NCT03193918 Arog Pharmaceuticals, Inc. Esophagogastric Adenocarcinoma April 14, 2017 Phase 1
NCT01287624 Fudan University|307 Hospital of PLA|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences|Sun Yat-sen University|Tianjin Medical University Cancer Institute and Hospital|Zhejiang Cancer Hospital|Changhai Hospital Breast Cancer January 2011 Phase 3
NCT01236547 National Cancer Institute (NCI) Thyroid Gland Undifferentiated (Anaplastic) Carcinoma October 28, 2010 Phase 2
NCT02178436 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Stage IV Pancreatic Cancer October 2014 Phase 1|Phase 2
NCT01881230 Celgene Breast Tumor|Breast Cancer|Cancer of the Breast|Estrogen Receptor- Negative Breast Cancer|HER2- Negative Breast Cancer|Progesterone Receptor- Negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer|Triple-negative Metastatic Breast Cancer|Metastatic Breast Cancer September 26, 2013 Phase 2|Phase 3
NCT00352300 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Infectious Disorder|Neutropenia|Ovarian Carcinosarcoma|Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer June 2006 Phase 1
NCT01779479 German Breast Group Primary Breast Cancer February 2013 Phase 2
NCT02718742 Mayo Clinic|National Cancer Institute (NCI) Recurrent Bladder Urothelial Carcinoma|Stage IV Bladder Urothelial Carcinoma June 2016 Phase 2
NCT01831089 PharmaMar Breast Cancer|Ovarian Cancer|Gynecological Cancer|Head and Neck Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Non-squamous Cell Lung Cancer September 2013 Phase 1
NCT01309607 National University Hospital, Singapore|National Cancer Centre, Singapore ErbB2-Positive Stage I-III Breast Cancer April 2011 Phase 2
NCT02204345 Hoffmann-La Roche Squamous Non-Small Cell Lung Cancer October 2014 Phase 1|Phase 2
NCT00954174 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Carcinosarcoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Sarcoma|Stage I Ovarian Cancer|Stage IA Fallopian Tube Cancer|Stage IA Ovarian Cancer|Stage IA Uterine Sarcoma|Stage IB Fallopian Tube Cancer|Stage IB Ovarian Cancer|Stage IB Uterine Sarcoma|Stage IC Fallopian Tube Cancer|Stage IC Ovarian Cancer|Stage IC Uterine Sarcoma|Stage II Ovarian Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cance August 2009 Phase 3
NCT01653912 Accenture Recurrent Platinum-resistant Ovarian Cancer December 2012 Phase 1|Phase 2
NCT01159418 Southern Europe New Drug Organization|Novartis Advanced Solid Tumors June 2008 Phase 1
NCT00288041 National Cancer Institute (NCI) Ciliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Recurrent Intraocular Melanoma|Recurrent Melanoma|Stage IV Melanoma October 2005 Phase 2
NCT00112489 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma May 2005 Phase 2
NCT00818090 Korean Cancer Study Group Thymoma|Thymic Carcinoma September 2008 Phase 2
NCT01620190 University of Washington|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer November 6, 2012 Phase 2
NCT02562898 Margaret Tempero|University of California, San Francisco Metastatic Pancreatic Adenocarcinoma October 2015 Phase 1|Phase 2
NCT02309177 Celgene Breast Neoplasms|Pancreatic Neoplasms January 14, 2015 Phase 1
NCT02001272 Hospices Civils de Lyon Ovarian Cancer December 2013 Phase 2
NCT00894569 Heidelberg University|Merck KGaA Neoplasms, Unknown Primary|Carcinoma July 2009 Phase 2
NCT00360360 SCRI Development Innovations, LLC|Genentech, Inc. Neoplasm, Unknown Primary July 2006 Phase 2
NCT01169870 National Cancer Center, Korea Breast Cancer July 2007 Phase 2
NCT00918203 Eli Lilly and Company Non-Small Cell Lung Cancer January 2010 Phase 2
NCT02481635 University Health Network, Toronto Pancreatic Cancer July 2016 Phase 1|Phase 2
NCT01745757 UNICANCER Metastatic|Breast Cancer June 2012
NCT01650376 Swedish Medical Center|AstraZeneca Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Uterine Cancer August 2012 Phase 1|Phase 2
NCT01063517 AstraZeneca Gastric Cancer February 2, 2010 Phase 2
NCT00093145 Celgene Corporation|Celgene Breast Cancer June 2004 Phase 2
NCT00004859 National Cancer Institute (NCI) Lung Cancer January 2000 Phase 3
NCT01506856 Gynecologic Oncology Trial & Investigation Consortium|Japanese Gynecologic Oncology Group Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma May 2010 Phase 2|Phase 3
NCT00174356 Pfizer Carcinoma, Non-Small Cell Lung December 2002 Phase 1
NCT01142388 National Cancer Institute (NCI) Adenocarcinoma of the Gastroesophageal Junction|Esophageal Adenocarcinoma|Esophageal Squamous Cell Carcinoma|Recurrent Esophageal Carcinoma|Stage IV Esophageal Cancer September 2010 Phase 2
NCT00002939 University of Chicago|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 1996 Phase 1
NCT01763671 Intergroupe Francophone de Cancerologie Thoracique Non-squamous Non-small Cell Lung Cancer May 2013 Phase 3
NCT02529878 The First Affiliated Hospital of Zhejiang Chinese Medical University|Jiangsu HengRui Medicine Co., Ltd. Gastric Cancer August 2015 Phase 2
NCT00005647 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer May 2000 Phase 1
NCT00575952 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mixed Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer January 2008 Phase 1
NCT00087217 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific May 2004 Phase 1
NCT02399137 Merrimack Pharmaceuticals Pancreatic Cancer May 2015 Phase 2
NCT02459457 Fudan University|Fudan University Shanghai Cancer Center Minhang Branch|Huadong Hospital|Wuxi No. 4 People's Hospital|Jiangsu Cancer Institute & Hospital|The First Affiliated Hospital of Xiamen University|Jiangxi Provincial Cancer Hospital|Shanxi Province Cancer Hospital|Gansu Cancer Hospital Stage III Esophageal Squamous Cell Carcinoma July 2015 Phase 3
NCT01276496 National Cancer Institute (NCI) Adult Solid Neoplasm|Estrogen Receptor Negative|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma December 2010 Phase 1
NCT03018080 Antoinette Tan|Merck Sharp & Dohme Corp.|Carolinas Healthcare System Breast - Female|Male Breast Cancer June 12, 2017 Phase 2
NCT00639522 Nanjing Sike Pharmaceutical Co., Ltd. Gastric Carcinoma May 2008 Phase 1
NCT02890511 Daehwa Pharmaceutical Co., Ltd. Solid Tumor|Stage IV Gastric Cancer August 2010 Phase 1|Phase 2
NCT00516724 AstraZeneca Triple Negative Metastatic Breast Cancer|Advanced Ovarian Cancer|Carboplatin|Paclitaxel June 29, 2007 Phase 1
NCT01485068 MINVASYS|European Cardiovascular Research Center In-stent Coronary Artery Restenosis March 2012
NCT02013154 Leap Therapeutics, Inc. Esophageal Neoplasms|Adenocarcinoma of the Gastroesophageal Junction|Gastroesophageal Cancer|Squamous Cell Carcinoma|Gastric Adenocarcinoma January 2014 Phase 1
NCT01317615 Novartis Pharmaceuticals|Novartis Carcinoma, Large Cell|Neuroendocrine Tumors April 2011 Phase 4
NCT00459121 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Lung Cancer July 2007 Phase 2
NCT00005059 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer January 2000 Phase 2
NCT00821028 University of Oklahoma Atherosclerosis|Angioplasty|Peripheral Arterial Disease January 2009
NCT02574663 TG Therapeutics, Inc.|SCRI Development Innovations, LLC Pancreatic Cancer|Colorectal Cancer|Rectal Cancer|Gastric Cancer|Esophageal Cancer|Gastrointestinal Stromal Tumor (GIST) October 2015 Phase 1
NCT01386385 National Cancer Institute (NCI) Bronchioloalveolar Carcinoma|Large Cell Lung Carcinoma|Lung Adenocarcinoma|Lung Adenocarcinoma, Mixed Subtype|Squamous Cell Lung Carcinoma|Stage III Non-Small Cell Lung Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer June 20, 2011 Phase 1|Phase 2
NCT01357161 Merck Sharp & Dohme Corp. Ovarian Cancer July 2011 Phase 2
NCT01491204 Hanmi Pharmaceutical Company Limited Advanced Solid Tumors August 2006 Phase 1
NCT02210559 FibroGen Pancreatic Cancer (Unresectable) July 2014 Phase 1|Phase 2
NCT00181701 Massachusetts General Hospital|Dana-Farber Cancer Institute|Brigham and Women's Hospital Ovarian Carcinoma October 2004 Phase 2
NCT00735696 Eli Lilly and Company Non Small Cell Lung Cancer January 2009 Phase 2
NCT00522834 Synta Pharmaceuticals Corp. Melanoma August 2007 Phase 3
NCT00368875 National Cancer Institute (NCI) Male Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer July 2006 Phase 1|Phase 2
NCT02047500 EMD Serono|Threshold Pharmaceuticals Pancreatic Cancer January 2014 Phase 1
NCT02835586 Hospices Civils de Lyon Critical Ischemia May 2013 Phase 3
NCT02163291 Peking University Advanced Gastric Carcinoma December 2013 Phase 2
NCT00915018 Puma Biotechnology, Inc. Breast Cancer August 2009 Phase 2
NCT00138151 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Cervical Cancer March 2001 Phase 2
NCT00462631 Heart Centre Rotenburg|B. Braun Medical SA Coronary Stenosis|Diabetes Mellitus May 2007 Phase 2|Phase 3
NCT00667641 University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2007 Phase 1
NCT01632371 Deutsches Herzzentrum Muenchen|Biotronik AG Restenosis|Stable Angina Pectoris|Acute Coronary Syndrome June 2012 Phase 4
NCT00331422 Masonic Cancer Center, University of Minnesota Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer October 2005 Phase 2
NCT01716715 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma November 2012 Phase 2
NCT02290470 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Nausea|Vomiting April 2014 Phase 2
NCT01827163 Memorial Sloan Kettering Cancer Center|GlaxoSmithKline HER2-Positive Early Stage Breast Cancer April 2013 Phase 2
NCT00344552 Bristol-Myers Squibb Esophageal Cancer June 2006 Phase 2
NCT01457846 AstraZeneca Gastro-oesophageal Junction Cancer|Gastric Cancer November 2011 Phase 2
NCT00291850 Central European Cooperative Oncology Group Non-Small Cell Lung Cancer June 2005 Phase 2
NCT01485081 MINVASYS|European Cardiovascular Research Center Coronary Disease May 2012
NCT02182232 Boehringer Ingelheim Carcinoma, Non-Small-Cell Lung June 2005 Phase 1
NCT02344095 Seoul National University Hospital Epithelial Ovarian Carcinoma|Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma December 2014 Phase 1
NCT02318095 Duke University Resectable Pancreatic Cancers January 2015
NCT01468909 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma December 2011 Phase 2
NCT01721525 Memorial Sloan Kettering Cancer Center|National Comprehensive Cancer Network|Boehringer Ingelheim Head and Neck Cancer|Squamous Cell Cancer November 2012 Phase 1
NCT02985333 Sun Yat-sen University Relapse/Refractory Multiple Myeloma January 2014 Phase 2
NCT00691379 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer April 2008 Phase 1|Phase 2
NCT00602797 University of Nebraska|National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer December 2007 Phase 2
NCT02573493 Washington University School of Medicine|Celgene Corporation Squamous Cell Carcinoma of the Head and Neck|Carcinoma, Squamous Cell of the Head and Neck|Cancer of Head and Neck|Cancer of the Head and Neck|Head and Neck Cancer|Neoplasms, Head and Neck April 13, 2016 Phase 2
NCT02279732 Bristol-Myers Squibb Lung Cancer (NSCLC) October 13, 2014 Phase 3
NCT00309959 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Small Cell Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma November 2006 Phase 2
NCT02632071 Kevin Kalinsky|Acetylon Pharmaceuticals Incorporated|National Cancer Institute (NCI)|Columbia University Metastatic Breast Cancer|Breast Carcinoma February 2016 Phase 1
NCT00691912 Claudia Lorenz-Schlüter|University of Magdeburg Metastatic Breast Cancer December 2006 Phase 2
NCT03047265 Sun Yat-sen University Nasopharyngeal Carcinoma February 4, 2017 Phase 2
NCT00006256 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer June 2000 Phase 2
NCT02138383 H. Lee Moffitt Cancer Center and Research Institute|Astellas Pharma Inc Pancreatic Cancer May 2014 Phase 1
NCT01285609 Bristol-Myers Squibb Lung Cancer - Non Small Cell (Squamous) August 2011 Phase 3
NCT01740336 Genentech, Inc. Breast Cancer February 6, 2013 Phase 2
NCT01764022 Biocad Human Epithelial Receptor (HER)-2 Positive Breast Cancer October 2012 Phase 3
NCT02464501 Horizons International Peripheral Group|Advanced Catheter Therapies, Inc. Peripheral Arterial Disease|Cardiovascular Disease|Peripheral Vascular Disease May 20, 2015
NCT01204320 Ospedale San Donato Stable Angina|Unstable Angina January 2008 Phase 4
NCT00408460 University of Washington|National Cancer Institute (NCI) Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer February 2006 Phase 2
NCT02054338 Pierre Fabre Medicament Advanced Breast Cancer June 2006 Phase 3
NCT00786110 University of Turin, Italy Adrenocortical Carcinoma April 2008 Phase 2
NCT00966914 BioNumerik Pharmaceuticals, Inc. Non-small Cell Lung Cancer April 2010 Phase 3
NCT00732953 University of Ulm|B. Braun Melsungen AG|OrbusNeich Coronary Artery Disease February 2009 Phase 2|Phase 3
NCT02920450 University of Florida|Pfizer Non-Small Cell Lung Cancer June 30, 2017 Phase 1|Phase 2
NCT02382406 Nisha Mohindra, MD|Hoosier Cancer Research Network|Merck Sharp & Dohme Corp.|Celgene Corporation Non-Small Cell Lung Cancer June 2015 Phase 1|Phase 2
NCT02145065 Balton Sp.zo.o.|American Heart of Poland Peripheral Artery Disease|Femoropopliteal Artery Disease September 2014
NCT00607438 Veeda Oncology|Bayer|Celgene Corporation Breast Cancer September 2007 Phase 2
NCT01321775 Hospital Universitario Madrid Sanchinarro Breast Cancer August 2009 Phase 2
NCT02412722 Millennium Pharmaceuticals, Inc.|Takeda Non-Hematologic Malignancy March 12, 2015 Phase 1
NCT02628951 Samsung Medical Center Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma May 26, 2016 Phase 2
NCT00709761 Novartis Pharmaceuticals|Novartis Neoplasms, Breast July 2008 Phase 2
NCT03149913 Prof. Dr. med. Gunnar Tepe|InnoRa GmbH|Klinikum Rosenheim Stenosis|Occlusion|Restenosis December 15, 2016
NCT02514031 University of Texas Southwestern Medical Center Pancreatic Cancer October 2015 Phase 1
NCT01413750 National Cancer Institute (NCI) Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer November 2010 Phase 1|Phase 2
NCT01770171 Catholic University of the Sacred Heart Stage III-IV or Recurrent Endometrial Cancer April 2012 Phase 2
NCT00003591 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Pancreatic Cancer November 1998 Phase 2
NCT00945191 Daiichi Sankyo Inc. Ovarian Cancer September 2009 Phase 2
NCT02549209 Daniela Matei, MD|Merck Sharp & Dohme Corp.|Hoosier Cancer Research Network|Big Ten Cancer Research Consortium Endometrial Cancer|Endometrial Adenocarcinoma July 2017 Phase 2
NCT03019588 Merck Sharp & Dohme Corp. Gastric Neoplasms|Gastroesophageal Junction Adenocarcinoma February 16, 2017 Phase 3
NCT00388076 GlaxoSmithKline Solid Tumor Cancer|Neoplasms, Breast April 2006 Phase 1
NCT01158144 Zhejiang Cancer Hospital Non-small Cell Lung Cancer October 2009 Phase 2
NCT02199418 RenJi Hospital Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Ductal Breast Cancer|Inflammatory Breast Cancer January 2013 Phase 2
NCT00307255 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific August 2006 Phase 1
NCT01186991 Genentech, Inc.|Hoffmann-La Roche Breast Cancer March 2011 Phase 2
NCT02033993 Canadian Cancer Trials Group|Australian and New Zealand Urogenital and Prostate Cancer Trials Group|Celgene Urothelial Cancer January 27, 2014 Phase 2
NCT01041027 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Stage IA Uterine Corpus Cancer|Stage IB Uterine Corpus Cancer|Stage II Uterine Corpus Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer September 2008 Phase 2
NCT01280058 National Cancer Institute (NCI) Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage IV Pancreatic Cancer December 2010 Phase 2
NCT03030287 OncoMed Pharmaceuticals, Inc. Cancer Ovaries|Cancer Peritoneal|Cancer, Fallopian Tube December 2016 Phase 1
NCT02106884 Universitaire Ziekenhuizen Leuven|Celgene Corporation Pancreatic Cancer April 2014 Phase 2
NCT02050009 Fox Chase Cancer Center|National Cancer Institute (NCI) Ovarian Papillary Serous Carcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Primary Peritoneal Cavity Cancer Phase 1
NCT02270814 Washington University School of Medicine|Celgene Corporation Head and Neck Cancer|Head and Neck Squamous Cell Carcinoma|Cancer of the Head and Neck February 2, 2015 Phase 2
NCT02607202 Fondazione del Piemonte per l'Oncologia Unknown Primary Tumors March 2015 Phase 2
NCT01816594 Novartis Pharmaceuticals|Breast International Group|German Breast Group (GBG)|SOLTI Breast Cancer Research Group|Novartis HER2-positive, Newly Diagnosed, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab September 2013 Phase 2
NCT00919880 Tao OUYANG|Peking University Breast Cancer July 2009 Phase 2
NCT01106898 University of Nebraska|National Cancer Institute (NCI) Stage I Breast Cancer|Stage II Breast Cancer March 2010 Phase 2
NCT01398033 Herz-Zentrums Bad Krozingen|Heart Center Bad Krozingen In-stent Stenosis of Infrapopliteal Arteries April 2012 Phase 3
NCT00329641 National Cancer Institute (NCI) Ciliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Metastatic Intraocular Melanoma|Recurrent Intraocular Melanoma February 2011 Phase 2
NCT01204125 Sanofi|SOLTI Breast Cancer Research Group Breast Cancer Female September 2010 Phase 2
NCT03154294 Avera McKennan Hospital & University Health Center Advanced Solid Tumor July 2017 Phase 1
NCT01281150 National Cancer Institute (NCI) Adult Solid Neoplasm|Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma January 2011 Phase 1
NCT01003158 AstraZeneca Neoplasms|Metastatic Cancer|Breast Cancer October 2009 Phase 1
NCT02667743 Shanghai Yizhong Biotechnology Co., Ltd. Non-Small Cell Lung Cancer(NSCLC) March 2015 Phase 3
NCT02503358 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer July 2016 Phase 1
NCT02812992 AIO-Studien-gGmbH Adenocarcinoma Pancreas June 2016 Phase 4
NCT02367794 Hoffmann-La Roche Squamous Non-Small Cell Lung Cancer June 11, 2015 Phase 3
NCT02048943 Roswell Park Cancer Institute|National Cancer Institute (NCI)|Novartis Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific March 2015 Phase 1
NCT01644825 National Cancer Institute, Naples Ovarian Cancer December 2010 Phase 2
NCT00255762 National Cancer Institute (NCI) Recurrent Melanoma|Stage IV Melanoma December 2005 Phase 2
NCT00661193 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer December 2008 Phase 2
NCT02530437 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Eli Lilly and Company Esophageal Cancer March 7, 2017 Phase 1|Phase 2
NCT02620800 Celgene Metastatic Pancreas Adenocarcinoma January 18, 2016 Phase 1|Phase 2
NCT02762474 Tianjin Medical University Cancer Institute and Hospital Esophageal Cancer July 2014 Phase 1|Phase 2
NCT01196741 University College, London|AstraZeneca|Cancer Research UK Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer March 2011 Phase 2|Phase 3
NCT02367781 Hoffmann-La Roche Non-Small Cell Lung Cancer April 30, 2015 Phase 3
NCT01506609 AbbVie (prior sponsor, Abbott)|AbbVie Metastatic Breast Cancer January 23, 2012 Phase 2
NCT00368992 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer August 2006 Phase 2
NCT00129389 Spanish Breast Cancer Research Group|Bristol-Myers Squibb Breast Cancer September 2003 Phase 3
NCT00373620 Korean Gynecologic Oncology Group Endometrial Cancer January 2006 Phase 2
NCT00788931 Novartis Pharmaceuticals|Novartis HER-2 Positive Breast Cancer|Metastatic Breast Cancer December 2008 Phase 1
NCT00107341 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer August 2005 Phase 2
NCT02732938 Pfizer Metastatic Pancreatic Ductal Adenocarcinoma May 4, 2016 Phase 2
NCT01428414 Zhimin Shao|Roche Pharma AG|Fudan University HER-2 Positive Breast Cancer August 2011 Phase 2
NCT00002189 Baker Norton Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 2
NCT00786552 University of Schleswig-Holstein Thyroid Cancer November 2008 Phase 2
NCT02617849 Wilson Miller|Jewish General Hospital Metastatic Malignant Melanoma March 2016 Phase 2
NCT01069796 ARCAGY/ GINECO GROUP Triple Negative Metastatic Breast Cancer April 2010 Phase 2
NCT02654119 University of Nebraska|National Cancer Institute (NCI) HER2 Positive Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer December 2015 Phase 2
NCT02677597 Fudan University Esophageal Squamous Cell Carcinoma January 2016 Phase 3
NCT02178956 Boston Biomedical, Inc Gastric Cancer|Gastroesophageal Junction Cancer August 2014 Phase 3
NCT00832819 Eisai Co., Ltd.|Eisai Inc. Non-small-cell Lung Cancer February 2009 Phase 1
NCT02629848 Takeda Carcinoma, Non-Small-Cell Lung July 2012 Phase 3
NCT00478361 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Urethral Cancer Associated With Invasive Bladder Cancer April 2007 Phase 2
NCT02725268 Millennium Pharmaceuticals, Inc.|European Network of Translational Research in Ovarian Cancer - EUTROC|European Network of Individualized Treatment in Endometrial Cancer - ENITEC|Takeda Endometrial Neoplasms April 1, 2016 Phase 2
NCT00408655 National Cancer Institute (NCI) Ovarian Sarcoma|Ovarian Stromal Cancer|Recurrent Endometrial Carcinoma|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Stage III Endometrial Carcinoma|Stage III Ovarian Epithelial Cancer|Stage III Ovarian Germ Cell Tumor|Stage IV Endometrial Carcinoma|Stage IV Ovarian Epithelial Cancer|Stage IV Ovarian Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific February 2007 Phase 1
NCT01730833 City of Hope Medical Center|National Cancer Institute (NCI) HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Breast Adenocarcinoma|Inflammatory Breast Carcinoma July 17, 2013 Phase 2
NCT01204749 Amgen Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer November 2010 Phase 3
NCT00131963 Duke University|National Cancer Institute (NCI) Breast Cancer October 2003
NCT00003281 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer April 1998 Phase 2
NCT02151812 Hemoteq AG Coronary Artery Disease|Coronary Restenosis|Coronary Atherosclerosis|Coronary Arteriosclerosis August 2014
NCT02628613 Fudan University Breast Cancer April 2015 Phase 3
NCT01239732 Hoffmann-La Roche Ovarian Cancer December 2010 Phase 3
NCT02560038 The University of Texas Health Science Center, Houston Urinary Bladder Neoplasms October 2015 Phase 2
NCT01618136 Eisai Limited|Eisai Inc. Malignant Solid Tumour|Ovarian Cancer|Triple Negative Breast Cancer|Advanced Melanoma|B-cell Malignancy, Low-grade January 2012 Phase 1|Phase 2
NCT01440998 National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Undifferentiated Carcinoma|Endometrioid Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer|Uterine Carcinosarcoma September 2011
NCT00422435 Conor Medsystems Coronary Disease January 2007 Phase 3
NCT00110695 NSABP Foundation Inc|Celgene Corporation Breast Neoplasms April 2005 Phase 2
NCT00986674 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer September 2009 Phase 2
NCT00730353 Hoosier Cancer Research Network|Pfizer Esophageal Cancer August 2008 Phase 2
NCT02403895 AstraZeneca Squamous Non Small Cell Lung Cancer April 2015 Phase 2
NCT00003350 National Cancer Institute (NCI) AIDS-related Kaposi Sarcoma March 1999 Phase 3
NCT01512199 Daiichi Sankyo Inc.|ACTIVA Metastatic Breast Cancer January 2012 Phase 1|Phase 2
NCT00708812 Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd Advanced Non-small Cell Lung Cancer July 2007 Phase 2
NCT02225652 Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Women With Primary Breast Cancer September 2010 Phase 2
NCT01281852 National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Recurrent Cervical Carcinoma|Stage IVB Cervical Cancer March 2011 Phase 1|Phase 2
NCT01081951 AstraZeneca Ovarian Cancer February 4, 2010 Phase 2
NCT00723957 R-Pharm Advanced/Metastatic Non-Small Cell Lung Cancer December 2008 Phase 2
NCT02455141 Shanghai Jiao Tong University School of Medicine Breast Neoplasm July 2015 Phase 3
NCT00399126 AEterna Zentaris Neoplasms November 2004 Phase 1
NCT01333085 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Head and Neck Cancer October 2009 Phase 1|Phase 2
NCT00617942 William Sikov|Yale University|Brown University Breast Cancer February 2008 Phase 2
NCT01001676 University Health Network, Toronto Renal Failure February 2012 Phase 2
NCT00662129 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer November 2008 Phase 2
NCT00343083 Department of Radiation Oncology|Bristol-Myers Squibb|University of Maryland Cancer of Head and Neck December 2004 Phase 2
NCT00915603 SCRI Development Innovations, LLC|Novartis Metastatic Breast Cancer July 2009 Phase 2
NCT03174275 UNC Lineberger Comprehensive Cancer Center|AstraZeneca|Celgene Carcinoma, Squamous Cell|Oral Cancer|Oropharynx Cancer|Larynx Cancer|Lip Cancer|Esophageal Cancer June 1, 2017 Phase 2
NCT01009515 New Mexico Cancer Care Alliance Melanoma August 2009 Phase 2
NCT00301028 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer April 2006 Phase 2
NCT01980810 Chinese Academy of Medical Sciences Gastric Cancer September 2013 Phase 2
NCT00108745 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIIA Fallopian Tube Cancer|St March 2005 Phase 3
NCT01270724 Nationwide Children's Hospital CNS Germ Cell Tumor August 2010 Phase 2
NCT02336087 City of Hope Medical Center|National Cancer Institute (NCI) Pancreatic Adenocarcinoma|Unresectable Pancreatic Carcinoma January 2016 Phase 1
NCT00445458 Puma Biotechnology, Inc. Advanced Breast Cancer|Advanced Malignant Solid Tumors|Breast Neoplasms September 2007 Phase 1|Phase 2
NCT00001387 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neoplasms September 1994 Phase 1
NCT00936702 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Carcinoma of Unknown Primary Origin September 2009 Phase 2
NCT01006252 Eli Lilly and Company Melanoma December 2009 Phase 3
NCT02442063 Bayer Neoplasms|Bone Diseases August 2015 Phase 1
NCT01560104 AbbVie (prior sponsor, Abbott)|AbbVie Non-Small -Cell Lung Cancer February 2012 Phase 2
NCT00496028 AstraZeneca Neoplasms March 2007 Phase 1
NCT00750386 Hellenic Oncology Research Group|University Hospital of Crete Ovarian Cancer January 2008 Phase 1|Phase 2
NCT01616303 Quest PharmaTech Inc. Ovarian Neoplasms June 2012 Phase 2
NCT00481078 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer May 2007 Phase 2
NCT02112552 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Endometrial Serous Adenocarcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC1 Uterine Corpus Cancer|Stage IIIC2 Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer May 2013 Phase 2
NCT02106546 AbbVie Squamous Non-Small Cell Lung Cancer April 2014 Phase 3
NCT00097227 ImClone LLC|Bristol-Myers Squibb Non-small Cell Lung Cancer November 2004 Phase 2
NCT01194869 Emory University|Amgen|Bayer Breast Cancer June 2010 Phase 2
NCT00287937 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 2005 Phase 1
NCT01858428 Spectranetics Corporation Peripheral Arterial Disease June 2013
NCT01702714 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer July 2014 Phase 1
NCT02317874 National Cancer Institute (NCI) BRCA Rearrangement|BRCA1 Gene Mutation|BRCA2 Gene Mutation|Deleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Metastatic Malignant Solid Neoplasm|Unresectable Solid Neoplasm July 24, 2015 Phase 1
NCT02155088 H. Lee Moffitt Cancer Center and Research Institute|Novartis Pancreatic Cancer October 30, 2014 Phase 1
NCT00851877 University of Texas Southwestern Medical Center Head and Neck Cancer March 2009 Phase 1|Phase 2
NCT01617928 AbbVie (prior sponsor, Abbott)|AbbVie Solid Tumors May 2012 Phase 1
NCT01649336 Array BioPharma Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer July 2012 Phase 1
NCT01285466 Novartis Pharmaceuticals|Novartis Metastatic or Locally Advanced Solid Tumors January 2011 Phase 1
NCT02263495 Asan Medical Center|Eisai Inc.|Dong-A ST Co., Ltd.|Samyang Biopharmaceuticals Corporation Metastatic Breast Cancer November 2014 Phase 2
NCT00606333 Cordis Corporation|Conor Medsystems Coronary Atherosclerosis March 2008
NCT01310244 Spectrum Pharmaceuticals, Inc|Onxeo Stage IV Non-small Cell Lung Cancer December 2010 Phase 1|Phase 2
NCT02451956 Samsung Medical Center Advanced Gastric Cancer January 7, 2015 Phase 2
NCT02448329 Samsung Medical Center Advanced Gastric Adenocarcinoma January 14, 2015 Phase 2
NCT00004055 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer November 1999 Phase 2
NCT02967133 Alliance Foundation Trials, LLC.|Celgene Corporation|Bristol-Myers Squibb Non-Small-Cell Lung Cancer Metastatic|Non-Small Cell Carcinoma of Lung, TNM Stage 4|Nonsmall Cell Lung Cancer|Non Small Cell Lung Cancer Recurrent December 2016 Phase 2
NCT01086579 Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus Coronary Artery Disease March 2010
NCT02506842 Fudan University Stage ⅠA Pancreatic Cancer|Stage ⅠB Pancreatic Cancer|Stage ⅡA Pancreatic Cancer|Stage ⅡB Pancreatic Cancer June 2015 Phase 3
NCT03179904 Mayo Clinic|National Cancer Institute (NCI) HER2 Positive Breast Carcinoma|Stage III Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer July 30, 2017 Phase 2
NCT00106587 University Hospital, Saarland Coronary Restenosis December 2003 Phase 1|Phase 2
NCT00176254 Susanne Arnold|Bristol-Myers Squibb|University of Kentucky Squamous Cell Carcinoma May 2000 Phase 2
NCT01219777 Ritu Salani|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer September 2010 Phase 1
NCT00439608 Brown University|Bristol-Myers Squibb Esophageal Cancer|Gastric Cancer October 2004 Phase 2
NCT00320541 Eli Lilly and Company|Genentech, Inc. Breast Cancer May 2006 Phase 2
NCT01239953 Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular|Hospital San Carlos, Madrid|B.Braun Surgical SA|Abbott Vascular In-Stent Restenosis January 2010 Phase 4
NCT02611700 Biotech Pharmaceutical Co., Ltd. Esophageal Squamous Cell Carcinomas November 2015 Phase 3
NCT01239940 Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular|Hospital San Carlos, Madrid|B.Braun Surgical SA|Abbott Vascular In-stent Restenosis January 2010 Phase 4
NCT01763710 Asociación Oncosur Breast Cancer December 2012 Phase 2
NCT00340184 Korean Gynecologic Oncology Group Cervical Cancer August 2004 Phase 2
NCT00576225 CTI BioPharma NSCLC September 2007 Phase 3
NCT00409981 University Hospital, Saarland Coronary Restenosis July 2004 Phase 1|Phase 2
NCT00369551 National Cancer Institute (NCI) Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Stage II Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer June 2006 Phase 1
NCT00322400 Amgen Locally Recurrent and Metastatic Breast Cancer March 2006 Phase 1
NCT00748553 University of Utah|Celgene Corporation Advanced or Metastatic Solid Tumors|Advanced or Metastatic Breast Cancer September 2008 Phase 1|Phase 2
NCT00448708 Angiotech Pharmaceuticals Kidney Diseases|ESRD March 2007
NCT02436668 Pharmacyclics LLC. Metastatic Pancreatic Adenocarcinoma May 2015 Phase 2|Phase 3
NCT02221999 RenJi Hospital Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Ductal Breast Cancer|Inflammatory Breast Cancer January 2014 Phase 2|Phase 3
NCT00093756 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer September 2004 Phase 1|Phase 2
NCT01187199 M.D. Anderson Cancer Center Advanced Cancer August 2010 Phase 1
NCT01367301 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Stage IA Uterine Sarcoma|Stage IB Uterine Sarcoma|Stage IC Uterine Sarcoma|Stage IIA Uterine Sarcoma|Stage IIB Uterine Sarcoma|Stage IIIA Uterine Sarcoma|Stage IIIB Uterine Sarcoma|Stage IIIC Uterine Sarcoma|Stage IVA Uterine Sarcoma|Stage IVB Uterine Sarcoma|Uterine Carcinosarcoma May 2011
NCT00129727 Massachusetts General Hospital|Women and Infants Hospital of Rhode Island Ovarian Cancer June 2005 Phase 2
NCT01774851 Merrimack Pharmaceuticals HER-2 Gene Amplification|Esophagus Cancer|Gastroesophageal Junction Cancer|Stomach Cancer January 2013 Phase 2
NCT00002587 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 1994 Phase 1
NCT00129922 Spanish Breast Cancer Research Group|Bristol-Myers Squibb|Pfizer|Hoffmann-La Roche Breast Cancer November 1999 Phase 3
NCT02483104 AbbVie Ovarian Cancer July 2015 Phase 1
NCT00752115 Hamamatsu University Non-small Cell Lung Cancer February 2007 Phase 2|Phase 3
NCT00844649 Celgene Metastatic Pancreatic Cancer March 2009 Phase 3
NCT00795899 German Breast Group|AGO Study Group Breast Cancer January 2002 Phase 2
NCT00006929 National Cancer Institute (NCI) Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer September 2000 Phase 2
NCT00603538 Pfizer Carcinoma, Non-Small-Cell Lung January 2008 Phase 1
NCT02723331 University of Colorado, Denver|Celgene Corporation|Criterium, Inc. Pancreatic Cancer|Pancreatic Adenocarcinoma|Pancreas Ductal Adenocarcinoma December 30, 2016 Phase 2
NCT02023710 Beijing Cancer Hospital Melanoma December 2013 Phase 2
NCT02661815 Dana-Farber Cancer Institute|Acetylon Pharmaceuticals Incorporated Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma January 2016 Phase 1
NCT00201734 Ohio State University Comprehensive Cancer Center|Roche Pharma AG Tumors|Unknown Primary Tumors|Adenocarcinoma June 2005 Phase 1|Phase 2
NCT01083537 University Health Network, Toronto Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Bowel Obstruction February 2010 Phase 1|Phase 2
NCT00393315 University Hospital, Saarland|B. Braun Melsungen AG In-Stent Restenosis November 2005 Phase 2
NCT01165216 Bristol-Myers Squibb Non-Small Cell Lung Cancer September 2010 Phase 1
NCT01998347 Shantou University Medical College Esophageal Cancer November 2013 Phase 3
NCT01204437 German Breast Group Breast Cancer March 2009 Phase 2|Phase 3
NCT01166542 Oncolytics Biotech Carcinoma, Squamous Cell of the Head and Neck June 2010 Phase 3
NCT02366143 Hoffmann-La Roche Non-Small Cell Lung Cancer March 31, 2015 Phase 3
NCT00226915 Japanese Gynecologic Oncology Group Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer April 2003 Phase 3
NCT00984464 Oncolytics Biotech|University of Texas Metastatic Melanoma September 2009 Phase 2
NCT02109445 Pfizer|Academic GI Cancer Consortium Metastatic Cancer Pancreas September 3, 2014 Phase 2
NCT00049257 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb Prostate Cancer October 2002 Phase 2
NCT03081143 Krankenhaus Nordwest Advanced Gastric or EGJ Cancer May 10, 2017 Phase 2
NCT02926183 Wakayama Medical University Pancreatic Ductal Adenocarcinoma October 2016 Phase 2
NCT00803556 Bristol-Myers Squibb Solid Tumor|Breast Cancer January 2006 Phase 1
NCT02879318 Canadian Cancer Trials Group|AstraZeneca Pancreatic Adenocarcinoma August 2016 Phase 2
NCT00666991 CritiTech, Inc.|University of Kansas Medical Center|Beckloff Associates, Inc. Peritoneal Neoplasms July 2008 Phase 1
NCT00005028 University of Maryland|National Cancer Institute (NCI) Prostate Cancer May 2000 Phase 2
NCT00183820 University of Southern California|Sanofi Testicular Cancer|Germ Cell Neoplasm November 2004 Phase 2
NCT02526953 Blokhin's Russian Cancer Research Center Anus Neoplasms|Carcinoma, Squamous Cell|Anus Diseases|Neoplasms|Neoplasms, Squamous Cell|Carcinoma January 2016 Phase 3
NCT00515073 M.D. Anderson Cancer Center Endometrial Cancer April 2001 Phase 2
NCT00062062 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer October 2004 Phase 2
NCT00297661 University of Bern|University of Zurich Coronary Heart Disease April 2003 Phase 4
NCT00891072 National Cancer Institute (NCI) Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular July 2009 Phase 1
NCT00331630 Northwestern University|GlaxoSmithKline|Celgene Corporation Breast Cancer May 2006 Early Phase 1
NCT01591135 Fudan University|Jiangsu Cancer Institute & Hospital|First Affiliated Hospital of Zhejiang University|The First Affiliated Hospital of Xiamen University|Fujian Cancer Hospital|Affiliated Hospital of Jiangnan University|Fudan University Shanghai Cancer Center Minhang Branch Esophageal Squamous Cell Carcinoma April 2012 Phase 3
NCT00680940 Cadila Pharnmaceuticals Non Small Cell Lung Cancer June 2008 Phase 2
NCT00998192 Oncolytics Biotech|University of Texas Metastatic or Recurrent Squamous Cell Carcinoma of the Lung October 2009 Phase 2
NCT00551733 CTI BioPharma|National Cancer Institute (NCI) Lung Cancer August 2007 Phase 3
NCT01010945 OSI Pharmaceuticals|Astellas Pharma Inc Advanced Pancreatic Cancer December 2009 Phase 1
NCT01395537 Case Comprehensive Cancer Center Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction August 2011 Phase 1|Phase 2
NCT00584857 University of Alabama at Birmingham Uterine Cancer July 2004 Phase 2
NCT01688609 National Cancer Institute (NCI) HER2-positive Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer July 2012 Phase 2
NCT02065687 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer March 2014 Phase 2|Phase 3
NCT00499603 M.D. Anderson Cancer Center|Novartis|National Cancer Institute (NCI) Breast Cancer July 2007 Phase 2
NCT00976573 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Melanoma (Skin) April 2010 Phase 2
NCT01676649 Jewish General Hospital Untreated Stage III Melanoma or Stage IV Melanoma November 2012 Phase 2
NCT01423123 NSABP Foundation Inc|Pfizer Breast Cancer May 2011 Phase 1
NCT01320111 Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH|iOMEDICO AG Metastatic Breast Cancer July 1, 2010 Phase 2
NCT00006276 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Psoriasis September 2000 Phase 2
NCT00095914 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific September 2004 Phase 1
NCT00080418 INSYS Therapeutics Inc Neoplasm July 2003 Phase 1
NCT00930930 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer June 2009 Phase 2
NCT02570711 Acerta Pharma BV Metastatic Pancreatic Cancer October 2015 Phase 2
NCT02142790 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Breast Cancer May 2014 Phase 4
NCT00023166 Enzon Pharmaceuticals, Inc. Neoplasm|Lymphomas|Neoplasm Metastasis May 2001 Phase 1
NCT03038100 Hoffmann-La Roche|GOG|ENGOT Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms March 8, 2017 Phase 3
NCT01196429 National Cancer Institute (NCI) Ovarian Clear Cell Cystadenocarcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer August 2010 Phase 2
NCT00675259 Ewa Mrozek|Celgene Corporation|Genentech, Inc.|Ohio State University Comprehensive Cancer Center Breast Cancer July 2008 Phase 2
NCT00846027 Hoffmann-La Roche Breast Cancer January 2009 Phase 2
NCT03026881 Jiangsu HengRui Medicine Co., Ltd.|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Recurrent and Metastatic Gastric Cancer January 2017 Phase 1
NCT01288261 University of Arizona|National Cancer Institute (NCI) Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer January 2011 Phase 1
NCT00004126 University of Chicago|National Cancer Institute (NCI) Lung Cancer November 1999 Phase 2
NCT00110019 National Cancer Institute (NCI) Mucosal Melanoma|Recurrent Melanoma|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin Melanoma June 2005 Phase 3
NCT01953536 Endocyte Breast Neoplasms April 2014 Phase 2
NCT00005032 University of Chicago|National Cancer Institute (NCI) Lung Cancer April 2000 Phase 1|Phase 2
NCT01763645 Biocad Non-small Cell Lung Cancer October 2012 Phase 3
NCT00003054 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma August 1997 Phase 2
NCT00001442 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Head and Neck Neoplasm|Squamous Cell Carcinoma July 1995 Phase 1
NCT00005849 University of Chicago|National Cancer Institute (NCI) Lung Cancer April 2000 Phase 2
NCT00022620 European Organisation for Research and Treatment of Cancer - EORTC Endometrial Cancer June 2001 Phase 2
NCT00785291 National Cancer Institute (NCI) Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|HER2/Neu Positive|Male Breast Carcinoma|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IIIC Breast Cancer AJCC v6|Stage IV Breast Cancer October 2008 Phase 3
NCT03058939 University of Chicago Breast Cancer|Breast Cancer Stage II|Breast Cancer Stage III November 2017 Phase 2
NCT00126581 National Cancer Institute (NCI) Adenosquamous Lung Carcinoma|Bronchioloalveolar Carcinoma|Lung Adenocarcinoma|Malignant Pericardial Effusion|Malignant Pleural Effusion|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer August 15, 2005 Phase 2
NCT00972205 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Cervical|Ovarian|Lung|Breast|Renal December 2007
NCT02269293 Memorial Sloan Kettering Cancer Center Ovarian Cancer|Endometrial Cancer October 13, 2014 Phase 1
NCT00088114 Synta Pharmaceuticals Corp. Neoplasms January 2003 Phase 1
NCT00002922 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer January 1997 Phase 2
NCT00003377 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer November 1999 Phase 1
NCT00002562 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer|Vaginal Cancer March 1994 Phase 2
NCT00768131 Eli Lilly and Company|ImClone LLC Lung Neoplasms|Carcinoma, Non-Small-Cell Lung October 2008 Phase 2
NCT02159820 Chinese PLA General Hospital Primary Malignant Neoplasm of Ovary|FIGO Stages II to IV June 2014 Phase 2|Phase 3
NCT00537173 Hoosier Cancer Research Network|United States Department of Defense|Indiana University School of Medicine|University of Colorado, Denver|Baylor University|McGill University Breast Cancer September 2007
NCT00002917 Mary Babb Randolph Cancer Center at West Virginia University Hospitals|National Cancer Institute (NCI) Bladder Cancer November 1996 Phase 1|Phase 2
NCT01711970 Vascular Biogenics Ltd. operating as VBL Therapeutics Platinum Resistant Ovarian Cancer November 2012 Phase 1|Phase 2
NCT00002928 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Ovarian Cancer January 1997 Phase 2
NCT00356681 Amgen Breast Neoplasms|Breast Tumors|Breast Cancer|Locally Recurrent and Metastatic Breast Cancer December 2006 Phase 2
NCT00616967 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2008 Phase 2
NCT00004265 University of Wisconsin, Madison|National Cancer Institute (NCI) Lung Cancer February 1999 Phase 2
NCT01293630 Sanofi Advanced Solid Tumors January 2011 Phase 1
NCT02739698 Maimónides Biomedical Research Institute of Córdoba Peritoneal Carcinomatosis July 2012 Phase 2
NCT00343291 Eli Lilly and Company|ImClone LLC Non-Small Cell Lung Cancer December 2006 Phase 2
NCT01016041 Maasstad Hospital Stable Angina|Unstable Angina|Acute Coronary Syndrome February 2007 Phase 3
NCT02322814 Hoffmann-La Roche Breast Cancer November 25, 2014 Phase 2
NCT00889382 Astellas Pharma Inc Solid Tumors|Ovarian Cancer July 2009 Phase 1|Phase 2
NCT01182610 Accelerated Community Oncology Research Network|Amgen Gastroesophageal Adenocarcinoma|Adenocarcinoma of the Distal Esophagus|Adenocarcinomas of the Gastroesophageal Junction|Adenocarcinoma of the Proximal Stomach April 2011 Phase 2
NCT00003327 Theradex|National Cancer Institute (NCI) Head and Neck Cancer September 1997 Phase 2
NCT00111787 GlaxoSmithKline Neoplasms, Breast April 11, 2005 Phase 2
NCT02810418 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neoplasms|Pancreatic Neoplasms June 10, 2016 Phase 1|Phase 2
NCT00003326 Theradex|National Cancer Institute (NCI) Esophageal Cancer September 1997 Phase 2
NCT02243007 Massachusetts General Hospital Resectable Pancreatic Cancer|Pancreatic Ductal Carcinoma September 2014 Phase 2
NCT00028535 National Cancer Institute (NCI) Male Breast Cancer|Recurrent Breast Cancer|Recurrent Endometrial Carcinoma|Recurrent Gastric Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Small Cell Lung Cancer November 2001 Phase 1
NCT01644890 Nippon Kayaku Co.,Ltd. Breast Cancer Nos Metastatic Recurrent July 2012 Phase 3
NCT02412371 AbbVie Non-small Cell Lung Cancer Stage III April 2015 Phase 2
NCT01570582 Korean Gynecologic Oncology Group Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer March 2010 Phase 2
NCT00130546 University Hospital Freiburg|Cordis Medizinische Apparate GmbH Coronary Artery Disease November 2004 Phase 3
NCT00272987 Novartis Neoplasms, Breast December 2005 Phase 3
NCT00023907 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer July 2001 Phase 2
NCT02073487 Jenny C. Chang, MD|Celgene Corporation|Novartis|The Methodist Hospital System Breast Cancer February 2014 Phase 2
NCT02504333 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) Metastatic Pancreatic Adenocarcinoma July 2015 Phase 1|Phase 2
NCT00006081 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer June 2000 Phase 2
NCT00002949 University of Chicago|National Cancer Institute (NCI) Bladder Cancer|Cervical Cancer|Endometrial Cancer|Vaginal Cancer July 1996 Phase 1
NCT02212015 Heidelberg University|Universitätsmedizin Mannheim|HELIOS Klinikum Berlin-Buch|University Hospital Dresden|Universitätsklinikum Hamburg-Eppendorf|University Hospital, Essen|Hannover Medical School|Klinikum der Universitaet Muenchen, Grosshadern|Medical University of Vienna|Medical University of Graz|Medical University Innsbruck|GlaxoSmithKline Angiosarcoma July 2014 Phase 2
NCT00088556 Telik Carcinoma, Non-Small-Cell Lung August 2004 Phase 1|Phase 2
NCT00054548 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific October 2002 Phase 1
NCT02142010 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Breast Cancer August 2014
NCT00513292 National Cancer Institute (NCI) HER2/Neu Positive|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer July 2007 Phase 3
NCT00942357 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage IA Uterine Corpus Cancer|Stage IB Uterine Corpus Cancer|Stage II Uterine Corpus Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer June 2009 Phase 3
NCT00955214 Society for Advancement of Coronary Intervention Research Stable Angina Pectoris|Unstable Angina Pectoris April 2009 Phase 4
NCT02430311 AstraZeneca Advanced Solid Tumours June 10, 2015 Phase 1
NCT00583830 Human Genome Sciences Inc. Non Small Cell Lung Cancer January 2007 Phase 2
NCT00486668 NSABP Foundation Inc|GlaxoSmithKline Invasive Breast Cancer July 2007 Phase 3
NCT00472472 University Hospital, Saarland Peripheral Arterial Disease April 2004 Phase 1|Phase 2
NCT00003193 Massachusetts General Hospital Head and Neck Cancer|Oral Complications January 1998 Phase 1|Phase 2
NCT01918254 Hoffmann-La Roche Breast Cancer August 6, 2013 Phase 1
NCT01090830 Holy Cross Hospital, Florida Non-Small-Cell Lung Carcinoma April 2010 Phase 1|Phase 2
NCT00094835 Amgen Lung Cancer|Non-Small Cell Lung Cancer January 2005 Phase 1|Phase 2
NCT00297804 Boston Scientific Corporation Coronary Artery Disease May 2002 Phase 2|Phase 3
NCT00113438 Mateon Therapeutics Cancer|Tumor March 2005 Phase 2
NCT00024375 Theradex|National Cancer Institute (NCI) Pancreatic Cancer June 2001 Phase 2
NCT01705691 NSABP Foundation Inc|Eisai Inc. Breast Cancer|HER2-negative Breast Cancer September 2012 Phase 2
NCT01593020 M.D. Anderson Cancer Center|Eisai Inc. Breast Cancer August 2012 Phase 2
NCT03132532 Mayo Clinic Non Small Cell Lung Cancer June 2017 Phase 2
NCT00653939 Mateon Therapeutics Tumors March 2008 Phase 2
NCT00024414 Theradex|National Cancer Institute (NCI) Prostate Cancer April 2001 Phase 2
NCT03092986 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Carcinoma, Non-Small-Cell Lung April 2017 Phase 3
NCT01911598 Genentech, Inc. Head and Neck Cancer September 19, 2013 Phase 1
NCT00003160 Theradex|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer September 1997 Phase 2
NCT02936622 Cook Peripheral Arterial Disease (PAD) February 21, 2017
NCT02183194 C. R. Bard Dysfunctional AV Graft|Dysfunctional AV Fistula July 2014
NCT00077688 OncoGenex Technologies Bladder Neoplasms|Ureteral Neoplasms|Urethral Neoplasms|Carcinoma, Transitional Cell November 2003 Phase 2
NCT01471132 Peking University Gastric Cancer|Metastases to Perineum September 2011 Phase 2
NCT00001383 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Cancer|Carcinoma, Renal Cell|Lymphoma|Ovarian Cancer March 1994 Phase 1
NCT01100931 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) NSCLC|Solid Tumors February 2010 Phase 1|Phase 2
NCT00995423 CardioVascular Research Foundation, Korea Coronary Artery Disease April 2008 Phase 4
NCT00022139 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer January 2002 Phase 2
NCT00459810 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Prostate Cancer February 2007 Phase 2
NCT00146575 Deutsches Herzzentrum Muenchen Coronary Disease June 2003 Phase 4
NCT00352690 Washington University School of Medicine|CTI BioPharma Carcinoma, Non-Small-Cell Lung April 2006 Phase 2
NCT02264990 AbbVie Non-squamous Non-small Cell Lung Cancer October 1, 2014 Phase 3
NCT00003440 National Cancer Institute (NCI) HER2-negative Breast Cancer|HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer July 1998 Phase 3
NCT01656538 Canadian Cancer Trials Group|Oncolytics Biotech Metastatic Breast Cancer July 30, 2012 Phase 2
NCT00816634 Samsung Medical Center First Line Chemotherapy|Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel|Advanced or Recurrent Esophageal Squamous Cell Carcinoma October 2008 Phase 2
NCT02715804 Halozyme Therapeutics Stage IV Pancreatic Ductal Adenocarcinoma February 2016 Phase 3
NCT00645177 AbbVie (prior sponsor, Abbott)|Genentech, Inc.|AbbVie Metastatic Breast Cancer July 2008 Phase 2
NCT00002969 Southwest Oncology Group|National Cancer Institute (NCI) Lung Cancer May 1997 Phase 2
NCT00647218 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer February 2000
NCT03126708 Peking University Esophageal Cancer, Squamous Cell|Cetuximab Effect|Chemotherapy Effect April 2017 Phase 2
NCT00158379 North Eastern Germany Society of Gynaecologic Oncology Ovarian Cancer July 2003 Phase 2
NCT00466960 University of Washington|National Cancer Institute (NCI) Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer May 2006 Phase 2
NCT02581943 Wake Forest University Health Sciences|National Cancer Institute (NCI) Recurrent Non-Small Cell Lung Carcinoma|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer May 2016 Phase 2
NCT02426281 Samsung Medical Center Pancreatic Ductal Adenocarcinoma June 4, 2015 Phase 2
NCT00147537 Pfizer Carcinoma, Non-Small-Cell Lung February 2005 Phase 1|Phase 2
NCT01215136 Matthew Galsky|Hoosier Cancer Research Network|Novartis Pharmaceuticals Transitional Cell Carcinoma|Bladder Carcinoma|Urothelial Carcinoma December 2010 Phase 2
NCT00301522 Boston Scientific Corporation Coronary Stenosis February 2003 Phase 2|Phase 3
NCT01848197 Taizhou Hospital Breast Cancer|Paclitaxel|Epirubicin|Cyclophosphamide May 2013
NCT01523678 Belgian Gynaecological Oncology Group Ovarian Cancer|Endometrial Cancer|Uterine Cervical Cancer February 2012 Phase 2
NCT02449655 Samsung Medical Center Advanced Gastric Adenocarcinoma February 12, 2015 Phase 2
NCT00770809 National Cancer Institute (NCI) HER2/Neu Positive|Male Breast Carcinoma|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer December 2008 Phase 3
NCT00089297 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer December 2004 Phase 2
NCT01836679 Chipscreen Biosciences, Ltd. Non-small-cell Lung Cancer April 2013 Phase 2
NCT00915369 Fresenius Kabi Oncology Ltd. Advanced Breast Cancer March 2009 Phase 1
NCT00955305 National Cancer Institute (NCI) Large Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer|Bronchioloalveolar Lung Carcinoma March 2010 Phase 2
NCT02520154 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Ovarian Cancer|Metastatic Ovarian Cancer July 2016 Phase 2
NCT00404235 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Melanoma (Skin) October 2006 Phase 2
NCT02370498 Merck Sharp & Dohme Corp. Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma May 2015 Phase 3
NCT00077246 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lung Cancer September 2003 Phase 1|Phase 2
NCT00063999 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer August 2003 Phase 3
NCT01419548 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neoplasms July 29, 2011 Phase 1
NCT02775435 Merck Sharp & Dohme Corp. Non-small Cell Lung Cancer June 9, 2016 Phase 3
NCT02158520 Academic and Community Cancer Research United|National Cancer Institute (NCI) Metastatic Melanoma|Mucosal Melanoma|Recurrent Melanoma|Stage IV Skin Melanoma|Stage IV Uveal Melanoma October 2013 Phase 2
NCT02172846 Washington University School of Medicine Carcinoma, Non-Small-Cell Lung May 22, 2014 Phase 1
NCT01820325 Novartis Pharmaceuticals|Novartis Non-Small Cell Lunch Cancer September 2013 Phase 1|Phase 2
NCT00038246 M.D. Anderson Cancer Center|Celgene Corporation Prostate Cancer October 2000 Phase 1|Phase 2
NCT01663727 Hoffmann-La Roche Metastatic Breast Cancer August 2012 Phase 3
NCT00136175 University of Michigan Cancer Center Bladder Cancer November 1999 Phase 2
NCT00226746 New York Methodist Hospital|Hani Ashamalla, MD, FCCP Carcinoma, Pancreatic Ductal March 2003 Phase 2
NCT00596830 Pfizer Carcinoma, Squamous Cell|Carcinoma, Adenosquamous|Carcinoma, Large Cell|Carcinoma, Non-Small-Cell Lung April 2008 Phase 3
NCT00041470 University of Washington|Amgen|Bristol-Myers Squibb|GlaxoSmithKline Breast Cancer March 2001 Phase 1|Phase 2
NCT00793897 Bristol-Myers Squibb Advanced Solid Tumors|Metastatic Solid Tumors April 2009 Phase 1
NCT00912639 Korean Breast Cancer Study Group Recurrent Breast Cancer May 2009 Phase 4
NCT01051934 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Non-Small Cell Lung Cancer|Adenocarcinoma December 29, 2009 Phase 1
NCT02621398 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey|Merck Sharp & Dohme Corp. Stage II Non-Small Cell Lung Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer April 2016 Phase 1
NCT00278122 University of Virginia|National Cancer Institute (NCI) Melanoma (Skin) July 2005 Phase 2
NCT01847326 University of Chicago|National Cancer Institute (NCI) Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Salivary Gland Squamous Cell Carci March 2013 Phase 1
NCT02550327 Baylor Research Institute Pancreatic Adenocarcinoma January 2016 Early Phase 1
NCT01163929 University of Kansas|Novartis|University of Kansas Medical Center Breast Cancer July 2010 Phase 2
NCT03086369 Eli Lilly and Company Metastatic Pancreatic Cancer May 11, 2017 Phase 1|Phase 2
NCT01921751 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer August 2013 Phase 2
NCT01587482 Nantes University Hospital Peripheral Arterial Disease December 2011
NCT00322569 Cordis Corporation|Conor Medsystems Coronary Disease July 2006 Phase 3
NCT02101021 Gilead Sciences Metastatic Pancreatic Ductal Adenocarcinoma June 2, 2014 Phase 3
NCT01593306 Indira Gandhi Medical College Carcinoma Cervix July 2011 Phase 3
NCT00806286 Daiichi Sankyo Inc. Metastatic Non-small Cell Lung Cancer December 2008 Phase 2
NCT00042809 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific May 2002 Phase 1
NCT00265733 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer February 2006 Phase 2
NCT00154804 National Taiwan University Hospital Esophageal Cancer August 2001 Phase 2
NCT00002972 European Organisation for Research and Treatment of Cancer - EORTC Lung Cancer January 1997 Phase 2
NCT00874848 Biothera NSCLC August 2009 Phase 2
NCT03125928 Fox Chase Cancer Center|Genentech, Inc. HER2-positive Breast Cancer June 6, 2017 Phase 2
NCT02898077 Eli Lilly and Company Gastroesophageal Junction Adenocarcinoma|Gastric Adenocarcinoma March 2, 2017 Phase 3
NCT00378313 NSABP Foundation Inc Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer|Breast Cancer|Locally Advanced November 2001 Phase 2
NCT00748163 Masonic Cancer Center, University of Minnesota Lung Cancer August 2008 Phase 2
NCT00084214 Synta Pharmaceuticals Corp. Melanoma May 2004 Phase 1|Phase 2
NCT00087802 Sanofi Carcinoma, Non-Small-Cell Lung March 2004 Phase 3
NCT02053597 Jules Bordet Institute Breast Cancer October 2014 Phase 2
NCT00295789 Haruhiko Fukuda|Ministry of Health, Labour and Welfare, Japan|Japan Clinical Oncology Group Uterine Cervical Neoplasms February 2006 Phase 3
NCT00453323 National Cancer Center, Korea Esophageal Cancer June 2006 Phase 2
NCT00609791 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer January 25, 2008 Phase 2
NCT01519804 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer April 2012 Phase 2
NCT02037529 Academic and Community Cancer Research United Metastatic Breast Cancer|Locally Recurrent Breast Cancer March 2014 Phase 3
NCT00729612 Greg Otterson|National Comprehensive Cancer Network|Celgene Corporation|Ohio State University Comprehensive Cancer Center Lung Cancer August 2008 Phase 2
NCT01320592 Abramson Cancer Center of the University of Pennsylvania Breast Cancer March 2011 Phase 1
NCT01862328 Millennium Pharmaceuticals, Inc.|Takeda Solid Tumors July 1, 2013 Phase 1
NCT00535119 National Cancer Institute (NCI) Adult Solid Neoplasm|BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Hereditary Breast and Ovarian Cancer Syndrome September 2007 Phase 1
NCT02743923 The Netherlands Cancer Institute|Dutch Society of Physicians for Pulmonology and Tuberculosis Carcinoma, Non-Small Cell Lung April 2016 Phase 3
NCT01493505 Amgen Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cancer January 2012 Phase 3
NCT00002632 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer March 1995 Phase 2
NCT02364999 Pfizer Non-small Cell Lung Cancer (NSCLC) April 20, 2015 Phase 3
NCT00002662 Aventis Pharmaceuticals|National Cancer Institute (NCI) Breast Cancer August 1994 Phase 3
NCT01090128 University of Utah|Celgene Corporation Stages II-III Breast Cancer September 2008 Phase 1
NCT00316407 Swedish Medical Center|GlaxoSmithKline Ovarian Epithelial Cancer Stage III|Stage IV Ovarian Cancer|Stage IV Breast Cancer August 2005 Phase 1|Phase 2
NCT00807768 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Fatigue|Neurotoxicity Syndrome|Obesity|Stage I Uterine Corpus Cancer|Stage II Uterine Corpus Cancer March 2009 Phase 3
NCT00373256 Pfizer Breast Neoplasms November 2006 Phase 3
NCT00733408 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer April 23, 2008 Phase 2
NCT00680758 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2008 Phase 1
NCT00642759 Massachusetts General Hospital|Dana-Farber Cancer Institute|Celgene Corporation|Genentech, Inc. Non-small Cell Lung Cancer April 2008 Phase 2
NCT01927068 Spectranetics Corporation Peripheral Arterial Disease July 2013
NCT00003117 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer October 1997 Phase 3
NCT00738699 Morphotek Ovarian Cancer September 2008 Phase 2
NCT00066716 Weill Medical College of Cornell University|Pfizer Esophageal Cancer June 2003 Phase 2
NCT00151060 University of Michigan Cancer Center Prostate Cancer December 1998 Phase 2
NCT01873326 Memorial Sloan Kettering Cancer Center|University of Southern California|Mayo Clinic|University of Pittsburgh|University of North Carolina|University of Chicago|Stanford University|University of Texas Southwestern Medical Center Germ Cell Tumors June 2013 Phase 2
NCT00421889 Onxeo Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Bladder Cancer August 2005 Phase 1|Phase 2
NCT00091377 MEI Pharma, Inc. Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer August 2004 Phase 1|Phase 2
NCT00077129 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Kidney Cancer September 2004 Phase 2
NCT00009802 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 1998 Phase 1
NCT02774473 Abramson Cancer Center of the University of Pennsylvania Breast Neoplasms February 2016
NCT01938846 Boehringer Ingelheim Neoplasms September 5, 2013 Phase 1
NCT00003230 Swiss Group for Clinical Cancer Research Leukemia January 1998 Phase 1|Phase 2
NCT00861627 Oncolytics Biotech Carcinoma, Non-small Cell Lung March 2009 Phase 2
NCT00063401 ImClone LLC|Bristol-Myers Squibb Ovarian Cancer|Peritoneal Neoplasms|Fallopian Tube Neoplasms September 2003 Phase 2
NCT00016315 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Lung Cancer May 2001 Phase 1
NCT00003299 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Eastern Cooperative Oncology Group|Southwest Oncology Group Lung Cancer April 1998 Phase 3
NCT00006459 Eli Lilly and Company Breast Cancer July 2000 Phase 3
NCT00084448 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer April 2004 Phase 2
NCT00014599 European Organisation for Research and Treatment of Cancer - EORTC Vulvar Cancer February 2001 Phase 2
NCT02051868 Royal Marsden NHS Foundation Trust|Cancer Research UK|Australasian Gastro-Intestinal Trials Group|ECOG-ACRIN Cancer Research Group|European Organisation for Research and Treatment of Cancer - EORTC|International Rare Cancers Initiative (IRCI ) This study is indorsed by IRCI Squamous Cell Carcinoma of the Anus December 2013 Phase 2
NCT00322452 AstraZeneca Non-Small Cell Lung Cancer March 2006 Phase 3
NCT02414685 National Cancer Institute, Slovakia Germ Cell Tumor April 2015 Phase 2
NCT00117442 Amgen Breast Cancer|Lung Cancer|Ovarian Cancer August 2002 Phase 2
NCT00262847 National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIIA Fallopian Tube September 2005 Phase 3
NCT00025688 Theradex|National Cancer Institute (NCI) Breast Cancer January 2001 Phase 3
NCT00096200 National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma August 2004 Phase 2
NCT02461043 Chinese Academy of Medical Sciences Esophageal Cancer April 2015 Phase 3
NCT00001450 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Carcinoma, Non-Small-Cell Lung|Lung Neoplasms September 1995 Phase 2
NCT00440674 Conor Medsystems Coronary Artery Disease February 2007 Phase 4
NCT00989651 National Cancer Institute (NCI) Fallopian Tube Carcinosarcoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Neoplasm|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Carcinosarcoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Tumor|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenoca October 28, 2009 Phase 1
NCT00879359 The Cleveland Clinic|Genentech, Inc. Endometrial Carcinoma December 2007 Phase 2
NCT00002937 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer June 1996 Phase 2
NCT02588443 Abramson Cancer Center of the University of Pennsylvania Pancreatic Cancer October 2015 Phase 1
NCT01036087 M.D. Anderson Cancer Center|Celgene Corporation|Amgen Breast Cancer November 2010 Phase 2
NCT00838656 Warwick Medical School|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer October 2007 Phase 2
NCT00964626 Russian Academy of Medical Sciences|National Cancer Institute (NCI) Ovarian Cancer April 2009 Phase 2
NCT01362374 Genentech, Inc. Neoplasms July 11, 2011 Phase 1
NCT02020707 Mayo Clinic|National Cancer Institute (NCI) Cervical Adenosarcoma|Cervical Adenosquamous Carcinoma|Cervical Carcinosarcoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma|Endometrial Mixed Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Transitional Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Fallopian Tube Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Mucinous Adenoc March 2014 Phase 1
NCT00434252 Genentech, Inc. Melanoma February 2007 Phase 2
NCT00347412 Cellectar Biosciences, Inc. Non Small Cell Lung Cancer November 2006 Phase 3
NCT00409383 Genta Incorporated Melanoma November 2006 Phase 1
NCT00005046 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer April 2000 Phase 1
NCT01253525 Eli Lilly and Company Adenocarcinoma November 2010 Phase 1
NCT00704145 A.O. Ospedale Papa Giovanni XXIII|Case Western Reserve University|Boston Scientific Corporation Coronary Artery Disease November 2007 Phase 4
NCT02358200 University of California, San Francisco|QuantumLeap Healthcare Collaborative Triple Negative Metastatic Breast Cancer|BRCA-mutated Solid Tumor February 23, 2015 Phase 1
NCT00584909 University of Alabama at Birmingham Uterine Cancer March 2006 Phase 2
NCT00003592 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer September 1998 Phase 3
NCT03168880 Tata Memorial Hospital Triple Negative Breast Cancer April 2010 Phase 3
NCT00408070 UConn Health|Genentech, Inc. Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Stage 3 Cancer|Stage 4 Cancer October 2006 Phase 2
NCT00004013 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Breast Cancer January 1999 Phase 2
NCT00193206 SCRI Development Innovations, LLC|Eli Lilly and Company|Celgene Corporation Breast Cancer September 2005 Phase 2
NCT01930292 Debiopharm International SA Solid Tumors April 2013 Phase 1
NCT01015118 Boehringer Ingelheim Ovarian Neoplasms|Peritoneal Neoplasms November 2009 Phase 3
NCT00316199 Eli Lilly and Company Metastatic Breast Cancer April 2006 Phase 2
NCT00367471 Novartis Pharmaceuticals|Novartis Neoplasms, Breast December 7, 2006 Phase 1
NCT00903942 University of Rochester|Celgene Corporation Non-small Cell Lung Cancer, Stage III March 2008 Phase 2
NCT01015339 Peking University|Roche Pharma AG Advanced Gastric Cancer November 2009 Phase 3
NCT02876107 M.D. Anderson Cancer Center|Amgen Malignant Neoplasm of Breast October 2016 Phase 2
NCT00041119 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer May 2002 Phase 3
NCT00189553 ARCAGY/ GINECO GROUP|Schering-Plough|Arbeitsgemeinschaft Gynaekologische Onkologie Austria|AGO Study Group|ANZGOG|European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group|NSGO Ovarian Cancer|Fallopian Tube Cancer April 2005 Phase 3
NCT02599363 Abramson Cancer Center of the University of Pennsylvania Advanced Breast Cancer January 2016 Phase 1
NCT01329627 Instituto do Cancer do Estado de São Paulo|Fundação Faculdade de Medicina Locally Advanced HER2-negative Breast Cancer August 2010 Phase 2
NCT00004057 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific December 1998 Phase 1
NCT02607332 Asan Medical Center Gastrointestinal Stromal Tumors November 2015 Phase 2
NCT00977574 National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer September 2009 Phase 2
NCT01009983 Wake Forest University Health Sciences Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer March 2010 Phase 2
NCT00655876 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Esophageal Cancer June 2008 Phase 3
NCT02501954 Women's Cancer Care Associates, LLC Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer March 2015 Phase 3
NCT01378533 Chinese Academy of Medical Sciences Breast Cancer May 2011 Phase 3
NCT01853748 Dana-Farber Cancer Institute Breast Cancer May 2013 Phase 2
NCT00334802 Eli Lilly and Company Metastatic Breast Cancer June 2006 Phase 2
NCT00270491 ARCAGY/ GINECO GROUP Breast Cancer|Neoplasm Metastasis December 2005 Phase 2
NCT02560298 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Anal Basaloid Carcinoma|Anal Canal Cloacogenic Carcinoma|Anal Squamous Cell Carcinoma|Metastatic Anal Canal Carcinoma|Recurrent Anal Canal Carcinoma|Stage IIIB Anal Canal Cancer|Stage IV Anal Canal Cancer January 2016 Phase 2
NCT02317419 Hoffmann-La Roche Cancer December 2014 Phase 1
NCT00003518 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Testicular Germ Cell Tumor January 1999 Phase 2
NCT01898117 The Netherlands Cancer Institute|Borstkanker Onderzoek Groep|Roche Pharma AG Breast Cancer July 2013 Phase 2
NCT00299026 Boston Scientific Corporation Coronary Artery Disease June 2001 Phase 2
NCT00387374 National Cancer Institute (NCI) Adenosquamous Cell Lung Cancer|Drug/Agent Toxicity by Tissue/Organ|Hemoptysis|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer October 2006 Phase 2
NCT00467012 Chugai Pharmaceutical Metastatic Breast Cancer April 2007 Phase 2
NCT00795340 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lung Cancer November 2008 Phase 3
NCT01042522 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Granulosa Cell Tumor|Ovarian Gynandroblastoma|Ovarian Sertoli-Leydig Cell Tumor|Ovarian Sex Cord Tumor With Annular Tubules|Ovarian Sex Cord-Stromal Tumor|Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types|Ovarian Steroid Cell Tumor February 2010 Phase 2
NCT00796991 Bristol-Myers Squibb|Medarex Advanced Melanoma February 2009 Phase 1
NCT00021372 Fox Chase Cancer Center|National Cancer Institute (NCI) Lymphoma February 1996 Phase 2
NCT00003717 St. Barnabas Medical Center|National Cancer Institute (NCI) Prostate Cancer October 1998 Phase 2
NCT00004173 Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific October 1999 Phase 1
NCT01031446 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Breast Cancer October 2009 Phase 1|Phase 2
NCT00003614 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Prostate Cancer December 1998 Phase 2
NCT00247208 North Texas Veterans Healthcare System|Clark R. Gregg Fund, Harris Methodist Foundation|University of Arkansas|VA Office of Research and Development|Michael Debakey Veterans Affairs Medical Center|Southern Arizona VA Health Care System|Onassis Cardiac Surgery Centre Coronary Artery Bypass|Arteriosclerosis May 2005 Phase 3
NCT02395705 Henan Cancer Hospital|Tianjin Medical University Cancer Institute and Hospital|Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Beijing Cancer Hospital|Hunan Province Tumor Hospital|Sun Yat-sen University Esophageal Neoplasm June 2015 Phase 3
NCT00281658 Novartis Neoplasms, Breast January 2006 Phase 3
NCT00533585 M.D. Anderson Cancer Center|Bayer Lung Cancer May 2006 Phase 1
NCT02625740 University of Rome Tor Vergata Peripheral Arterial Disease, Angioplasty November 2013
NCT00005649 Hoffmann-La Roche|National Cancer Institute (NCI) Breast Cancer July 1998 Phase 2
NCT00479817 Amgen Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer July 5, 2007 Phase 2
NCT00031876 Swiss Group for Clinical Cancer Research Breast Cancer May 2000 Phase 1|Phase 2
NCT00176267 Susanne Arnold|Bristol-Myers Squibb|University of Kentucky Squamous Cell Carcinoma September 2002 Phase 2
NCT00001569 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Carcinoma|Peritoneal Neoplasm January 1997 Phase 1
NCT00006257 City of Hope Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific November 2000 Phase 1
NCT02121990 Memorial Sloan Kettering Cancer Center|AstraZeneca|Genentech, Inc. Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer April 21, 2014 Phase 1
NCT02012192 Medical University Innsbruck|European Commission Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer June 2014 Phase 1|Phase 2
NCT00326456 National Cancer Institute, Naples Ovarian Cancer January 2003 Phase 3
NCT00003896 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer September 1999 Phase 2
NCT00245154 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lung Cancer September 2005 Phase 2|Phase 3
NCT01156961 Hoffmann-La Roche Breast Cancer October 2010 Phase 4
NCT03101748 M.D. Anderson Cancer Center|Puma Biotechnology, Inc. Malignant Neoplasm of Breast June 2017 Phase 1|Phase 2
NCT00600340 Central European Cooperative Oncology Group Metastatic Breast Cancer April 2008 Phase 3
NCT01334268 Medtronic Vascular Ischemic Heart Disease|Stenotic Coronary Lesion|Cardiovascular Diseases|Arteriosclerosis|Coronary Artery Disease September 2011
NCT00403130 George Albert Fisher|Genentech, Inc.|Eli Lilly and Company|Stanford University Breast Cancer|Metastatic Breast Cancer February 2006 Phase 2
NCT00003555 State University of New York - Upstate Medical University|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1998 Phase 1
NCT00724386 University of Chicago|Amgen Breast Cancer June 1999 Phase 1
NCT00370552 R-Pharm Metastatic Breast Cancer March 2007 Phase 2
NCT01260870 Bayer PAD August 2011 Phase 2
NCT00004159 University of Alabama at Birmingham|National Cancer Institute (NCI) Lung Cancer February 2000 Phase 1|Phase 2
NCT02048020 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Human Papilloma Virus Infection|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Verrucous Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinom December 26, 2013 Phase 2
NCT00251472 Veeda Oncology|Celgene Corporation Metastatic Breast Cancer March 2005 Phase 2
NCT00006120 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Breast Cancer May 2000 Phase 2
NCT01332656 Sanofi Ovarian Cancer Recurrent May 2011 Phase 2
NCT00916279 C. R. Bard In-Stent Restenosis June 2009 Phase 1|Phase 2
NCT00003206 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer April 1998 Phase 2
NCT00019019 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Breast Cancer|Kidney Cancer|Lung Cancer|Lymphoma|Melanoma (Skin)|Ovarian Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific October 1994 Phase 1
NCT00226590 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) Lung Cancer April 2003 Phase 2
NCT03169335 Qilu Pharmaceutical Co., Ltd. Non-squamous Non-small Cell Lung Cancer December 1, 2017 Phase 3
NCT02562716 Southwest Oncology Group|National Cancer Institute (NCI) Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma October 2015 Phase 2
NCT01069328 Bayer Carcinoma, Non-Small-Cell Lung|Lung Cancer July 2006 Phase 1
NCT02598310 Osaka Medical College Breast Cancer|Estrogen Receptor Negative Neoplasm|HER-2 Positive Breast Cancer November 2015 Phase 2
NCT01970579 B. Braun Melsungen AG Stenosis|Restenosis October 2013 Phase 3
NCT00005599 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer February 2000 Phase 2
NCT00803062 National Cancer Institute (NCI) Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma|Stage IVB Cervical Cancer April 2009 Phase 3
NCT02250599 Sun Yat-sen University Nasopharyngeal Neoplasms August 2014 Phase 2
NCT00716534 AbbVie (prior sponsor, Abbott)|Genentech, Inc.|AbbVie Advanced or Metastatic Non-Small Cell Lung Cancer June 2008 Phase 2
NCT00861705 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Triple-Negative Breast Carcinoma May 2009 Phase 2
NCT00434226 Genentech, Inc. Non-Small Cell Lung Cancer March 2007 Phase 2
NCT00004924 Yale University|National Cancer Institute (NCI) Lung Cancer March 1999 Phase 2
NCT00004979 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific Phase 1|Phase 2
NCT00006245 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Esophageal Cancer July 2000 Phase 2
NCT01989676 Pfizer Metastatic Breast Cancer February 24, 2014 Phase 3
NCT01980472 Grupo de Investigación y Divulgación Oncológica Non-small Cell Lung Cancer (NSCLC) August 2013 Phase 2
NCT00002717 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1996 Phase 3
NCT00060359 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer|Undifferentiated Ovarian Carcinoma April 2003 Phase 1
NCT00401674 National Cancer Institute, Naples Ovarian Cancer June 2003 Phase 2
NCT02717091 Nagoya University Borderline Resectable Pancreatic Cancer July 2015 Phase 2
NCT00176241 Susanne Arnold|Eli Lilly and Company|University of Kentucky Head and Neck Cancer December 2005 Phase 1
NCT00789581 SCRI Development Innovations, LLC|Bristol-Myers Squibb Breast Cancer December 2008 Phase 3
NCT00005635 Genentech, Inc.|National Cancer Institute (NCI) Breast Cancer January 2000 Phase 2
NCT01494415 First People's Hospital of Hangzhou Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous Cell July 2012 Phase 2
NCT00607048 Hoffmann-La Roche Neoplasms November 2007 Phase 1
NCT00031577 Children's Hospital of Philadelphia Brain and Central Nervous System Tumors August 1999 Phase 1
NCT02639650 Weiguo Lv|First Affiliated Hospital of Zhongshan Medical University|Shandong University|Huazhong University of Science and Technology|Women's Hospital School Of Medicine Zhejiang University Gestational Trophoblastic Neoplasms March 2016 Phase 3
NCT01868022 GlaxoSmithKline Cancer October 9, 2013 Phase 1
NCT00974584 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer October 2009 Phase 1
NCT00392392 SCRI Development Innovations, LLC|Celgene Corporation|Genentech, Inc. Breast Cancer October 2006 Phase 2
NCT00518284 Celgene Corporation|Celgene Vascular Disease, Peripheral January 2008 Phase 2
NCT03003546 Mayo Clinic|National Cancer Institute (NCI) Aggressive Non-Hodgkin Lymphoma|CD20 Positive|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma August 2017 Phase 1
NCT00618657 University of California, Irvine|National Institutes of Health (NIH)|National Cancer Institute (NCI) Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer February 2008 Phase 2
NCT00960960 Genentech, Inc. Breast Cancer August 2009 Phase 1
NCT00020007 National Cancer Institute (NCI) Lung Cancer|Metastatic Cancer December 1999 Phase 1
NCT01735825 University Hospital Ostrava Restenosis January 2012 Phase 4
NCT00874107 Biothera Non-Small Cell Lung Cancer June 2009 Phase 2
NCT02565953 Fundación Pública Andaluza Progreso y Salud|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud Arteriovenous Fistula Renal Dialysis Devices Obstruction October 2015 Phase 3
NCT00687687 Sanofi|Gynecologic Oncology Group Uterine Carcinosarcoma May 2008 Phase 2
NCT00616031 Kyoto University|Translational Research Informatics Center, Kobe, Hyogo, Japan|National Cancer Institute (NCI) Lung Cancer January 2008 Phase 2
NCT00807859 Amgen Breast Cancer|Breast Neoplasms|Breast Tumors|Cancer|Locally Recurrent and Metastatic Breast Cancer|Metastases|Metastatic Cancer|Oncology|Solid Tumors|Tumors March 2009 Phase 1
NCT01131195 Swiss Group for Clinical Cancer Research Breast Cancer July 19, 2010 Phase 3
NCT01316757 Fox Chase Cancer Center|National Cancer Institute (NCI) Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Na February 16, 2011 Phase 2
NCT01294293 Gynecologic Oncology Group|National Cancer Institute (NCI) Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Ovarian Carcinoma March 2011 Phase 1
NCT00520013 Dana-Farber Cancer Institute|Genentech, Inc.|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Massachusetts General Hospital Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|Papillary Serous Mullerian Tumor|Clear Cell Mullerian Tumor August 2007 Phase 2
NCT00809133 Boehringer Ingelheim Neoplasms May 2007 Phase 1
NCT00589238 National Cancer Centre, Singapore Breast Cancer January 2008 Phase 2
NCT00753038 Oncolytics Biotech Carcinoma, Squamous Cell of the Head and Neck August 2008 Phase 2
NCT00003622 George Washington University|National Cancer Institute (NCI) Prostate Cancer January 1999 Phase 2
NCT00054210 CTI BioPharma|National Cancer Institute (NCI) Lung Cancer January 2003 Phase 3
NCT01256268 H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme Corp. Endometrial Cancer|Ovarian Cancer June 13, 2011 Phase 1
NCT01281176 National Cancer Institute (NCI) Adult Solid Neoplasm February 9, 2011 Phase 1
NCT00526890 Roswell Park Cancer Institute Lung Cancer October 2006 Phase 2
NCT02607982 Hangzhou Cancer Hospital Esophageal Cancer|Concurrent Chemoradiotherapy|Oxaliplatin|Paclitaxel January 2005 Phase 2
NCT00499525 Northwestern University|Amgen Breast Cancer June 2007 Phase 2
NCT00600821 Pfizer Non-Small-Cell Lung Carcinoma|Adenocarcinoma April 2008 Phase 2
NCT01666418 University of Zurich Melanoma August 2012 Phase 2
NCT00003539 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer April 1998 Phase 2
NCT02551055 Millennium Pharmaceuticals, Inc.|Takeda Neoplasms, Advanced or Metastatic September 2015 Phase 1
NCT00151034 University of Michigan Cancer Center|Genentech, Inc. Urologic Neoplasms September 2000 Phase 2
NCT01023347 Samyang Biopharmaceuticals Corporation Non Small Cell Lung Cancer June 2008 Phase 2
NCT01167712 National Cancer Institute (NCI) Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB September 2010 Phase 3
NCT00147680 Queensland Centre for Gynaecological Cancer Uterine Cancer September 2004 Phase 2
NCT00618826 Barbara Ann Karmanos Cancer Institute|Eli Lilly and Company|Genentech, Inc. Metastatic Breast Cancer November 2006 Phase 2
NCT02726997 M.D. Anderson Cancer Center|AstraZeneca Malignant Neoplasms of Female Genital Organs|Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer July 2016 Phase 1|Phase 2
NCT02256436 Merck Sharp & Dohme Corp. Urothelial Cancer October 22, 2014 Phase 3
NCT01578551 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Carcinoma, Non-Small-Cell Lung|Lung Adenocarcinoma April 2012 Phase 2
NCT02488967 NRG Oncology|National Cancer Institute (NCI) Breast Adenocarcinoma|Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma July 2015 Phase 3
NCT01960647 Eurocor GmbH Peripheral Artery Disease May 2011 Phase 3
NCT02066103 Mercator MedSystems, Inc.|National Cancer Institute (NCI) Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer January 2014
NCT00081042 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Melanoma (Skin) February 2004 Phase 2
NCT00001426 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Ovarian Neoplasm February 3, 1995 Phase 2
NCT00407888 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-positive Breast Cancer|HER2-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer May 2006 Phase 2
NCT00006229 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lung Cancer April 2000 Phase 2|Phase 3
NCT01858363 Spectranetics Corporation Peripheral Arterial Disease|Claudication November 2012
NCT00960297 SCRI Development Innovations, LLC|Genentech, Inc. Non-Small Cell Lung Cancer August 2009 Phase 2
NCT00004863 Montefiore Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific July 1999 Phase 1
NCT00035152 Bristol-Myers Squibb Carcinoma, Non-Small-Cell Lung June 2000 Phase 3
NCT00193596 SCRI Development Innovations, LLC|AstraZeneca|Pharmacia and Upjohn|Eli Lilly and Company Neoplasms, Unknown Primary September 2003 Phase 3
NCT02948075 NewVac LLC|Janssen Pharmaceutica N.V., Belgium Ovarian Cancer September 2015 Phase 2
NCT00191646 Eli Lilly and Company Genital Neoplasms, Female|Fallopian Tube Neoplasms|Ovarian Neoplasms|Pelvic Neoplasms|Peritoneal Neoplasms October 2002 Phase 3
NCT00083057 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Head and Neck Cancer May 2004 Phase 1
NCT02327169 Millennium Pharmaceuticals, Inc.|Takeda Advanced Nonhematologic Malignancies February 2, 2015 Phase 1
NCT01989780 Japan Breast Cancer Research Group|Chugai Pharmaceutical Metastatic Breast Cancer January 2014 Phase 2
NCT01225302 Abbott Non-Small Cell Lung Cancer September 2010 Phase 1
NCT02593708 Michelle Melisko|University of California, San Francisco Solid Tumor October 2015 Phase 1
NCT02194829 National Cancer Institute (NCI) Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic Carcinoma July 1, 2014 Phase 1|Phase 2
NCT00093223 Celgene Corporation Angina Pectoris|Coronary Artery Disease September 2001 Phase 2
NCT00539331 AstraZeneca Carcinoma, Non-Small-Cell Lung September 2007 Phase 1
NCT01697293 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Breast Adenocarcinoma|Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer January 2012 Phase 1|Phase 2
NCT01227408 University of Southern California|CTI BioPharma Breast Cancer February 2009 Phase 2
NCT00951665 Genentech, Inc. Metastatic Breast Cancer August 2009 Phase 1|Phase 2
NCT01830270 Centre Hospitalier Universitaire de Besancon Stomach Neoplasms|Oesophageal Junction Cancer|Lower Oesophagus Cancer May 2011 Phase 2
NCT00276796 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer Phase 2
NCT02258659 University of Chicago|National Cancer Institute (NCI) Human Papilloma Virus Infection|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVB Squamous Cell Carcinoma of the Oropharynx September 2014 Phase 2
NCT00511459 Amgen Locally Recurrent and Metastatic Breast Cancer July 2007 Phase 2
NCT00017407 Ionis Pharmaceuticals, Inc.|National Cancer Institute (NCI) Lung Cancer October 2000 Phase 3
NCT00016406 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer May 2001 Phase 3
NCT01938872 Ospedale San Donato Critical Limb Ischemia September 2013
NCT00513695 University of Washington|National Cancer Institute (NCI) Inflammatory Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer June 2007 Phase 2
NCT01031212 University of California, San Francisco|Novartis Pharmaceuticals Tumors January 2010 Phase 1
NCT00578149 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Non-Small Cell Lung Cancer May 2006 Phase 2
NCT00034346 Amgen Non-Small Cell Lung Cancer|Neoplasm Metastasis|Lung Cancer January 2002 Phase 2
NCT01855828 Lajos Pusztai|Genentech, Inc.|Yale University Her2-Positive Breast Cancer September 2013 Phase 2
NCT00005087 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Head and Neck Cancer March 2000 Phase 2
NCT03002103 SynCore Biotechnology Co., Ltd. Triple-Negative Breast Cancer November 2016 Phase 3
NCT02954172 Innovent Biologics (Suzhou) Co. Ltd.|WuXi CDS Clinical Research (Shanghai) Co.Ltd. NSCLC November 2016 Phase 3
NCT00936780 Sahajanand Medical Technologies Pvt. Ltd. Coronary Artery Disease July 2008 Phase 4
NCT02845908 Fujian Cancer Hospital Malignant Neoplasm of Stomach Stage IV September 2016 Phase 2
NCT00006454 AGO Study Group Fallopian Tube Cancer|Ovarian Cancer December 1999 Phase 3
NCT00314678 John P. Fruehauf|GlaxoSmithKline|University of California, Irvine Epithelial Ovarian Cancer|Primary Peritoneal Cancer September 2005 Phase 2
NCT00946712 Southwest Oncology Group|National Cancer Institute (NCI) Recurrent Large Cell Lung Carcinoma|Recurrent Lung Adenocarcinoma|Recurrent Squamous Cell Lung Carcinoma|Stage IV Large Cell Lung Carcinoma|Stage IV Lung Adenocarcinoma|Stage IV Squamous Cell Lung Carcinoma July 2009 Phase 3
NCT00807612 NantCell, Inc. Advanced Squamous Non-Small Cell Lung Cancer January 2009 Phase 1|Phase 2
NCT00423852 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor August 2006 Phase 1|Phase 2
NCT01081262 National Cancer Institute (NCI) Borderline Ovarian Mucinous Tumor|Ovarian Mucinous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Stage IA Fallopian Tube Cancer|Stage IA Ovarian Cancer|Stage IB Fallopian Tube Cancer|Stage IB Ovarian Cancer|Stage IC Fallopian Tube Cancer|Stage IC Ovarian Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIIA Fallopian Tube Cance October 12, 2010 Phase 3
NCT00084565 Fox Chase Cancer Center Prostate Cancer November 2003 Phase 2
NCT00025389 University of Chicago|National Cancer Institute (NCI) Lung Cancer November 2001 Phase 2
NCT00071188 Genzyme, a Sanofi Company|Sanofi Carcinoma, Non-Small-Cell Lung February 2004 Phase 2
NCT02965677 ZhuHai Cardionovum Medical Device Co., Ltd. Peripheral Arterial Disease December 2016
NCT02065466 University of Arizona Metastatic Melanoma|Brain Metastases July 2014 Phase 1|Phase 2
NCT02921022 Memorial Sloan Kettering Cancer Center|Halozyme Therapeutics|Miami Cancer Institute Pancreatic Cancer|Advanced Pancreatic Ductal Adenocarcinoma October 2016
NCT01796197 Dana-Farber Cancer Institute Breast Cancer March 2013 Phase 2
NCT01769391 Eli Lilly and Company Squamous Non Small Cell Lung Cancer January 2013 Phase 2
NCT00489541 Boston Scientific Corporation Coronary Artery Disease July 2007 Phase 3
NCT02207465 Abramson Cancer Center of the University of Pennsylvania Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy|Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy July 2014 Phase 1
NCT01075464 Genentech, Inc. Solid Cancers February 2010 Phase 1
NCT00001499 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Carcinoma, Non-Small-Cell Lung|Lung Neoplasms March 1996 Phase 2
NCT00490711 Eli Lilly and Company Epithelial Ovarian Cancer July 2003 Phase 2
NCT00546156 Ian E. Krop, MD, PhD|Genentech, Inc.|Massachusetts General Hospital|Brigham and Women's Hospital|New Hampshire Oncology-Hematology PA|Dana-Farber Cancer Institute Breast Cancer October 2007 Phase 2
NCT01752205 The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Esophageal Squamous Carcinoma November 2012 Phase 3
NCT00057928 Southwest Oncology Group|National Cancer Institute (NCI) Cervical Cancer April 2003 Phase 3
NCT01303926 Gruppo Oncologico Italia Meridionale Non-squamous Nonsmall Cell Neoplasm of Lung January 2010 Phase 3
NCT00170664 North Eastern Germany Society of Gynaecologic Oncology Ovarian Cancer January 1999 Phase 2
NCT00003128 Gynecologic Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Sarcoma November 1997 Phase 3
NCT00397761 Washington Hospital Center|National Cancer Institute (NCI) Breast Cancer July 2006 Phase 2|Phase 3
NCT00193531 SCRI Development Innovations, LLC|Bristol-Myers Squibb Neuroendocrine Carcinoma December 1998 Phase 2
NCT01172223 Prof Dirk Elling|Sana-Klinikum Lichtenberg Breast Cancer September 2007 Phase 1|Phase 2
NCT03155971 The People's Hospital of Liaoning Province Stable Angina Pectoris|Unstable Angina Pectoris July 1, 2017
NCT00009828 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific December 1999 Phase 1
NCT01526369 Cancer Trials Ireland Metastatic Breast Cancer January 2012 Phase 3
NCT00028587 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific December 2001 Phase 1
NCT00276588 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer July 2005 Phase 2
NCT00016874 Vion Pharmaceuticals|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific December 2000 Phase 1
NCT00598247 University of Southern California|CTI BioPharma|ASCEND Therapeutics Advanced Colorectal Cancer January 2008 Phase 1
NCT01024712 Cancer Institute and Hospital, Chinese Academy of Medical Sciences|National Cancer Institute (NCI) Lung Cancer May 2009 Phase 2
NCT00193297 SCRI Development Innovations, LLC|GlaxoSmithKline Ovary Cancer February 2002 Phase 2
NCT00088088 Synta Pharmaceuticals Corp. Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer March 2004 Phase 1|Phase 2
NCT00111007 Bayer|Amgen Melanoma May 2005 Phase 3
NCT02395744 Horizons International Peripheral Group|Advanced Catheter Therapies, Inc. Cardiovascular Diseases|Peripheral Vascular Disease|Arterial Occlusive Diseases|Peripheral Arterial Disease|Critical Limb Ischemia March 11, 2015
NCT00544167 SCRI Development Innovations, LLC|Bayer Breast Cancer May 2007
NCT00318136 Genentech, Inc. Non-small Cell Lung Cancer September 2005 Phase 2
NCT02307227 Centro di Riferimento Oncologico - Aviano Breast Neoplasms April 2006 Phase 2
NCT00997906 National Cancer Centre, Singapore Head and Neck Cancer September 2009 Phase 2|Phase 3
NCT00154882 National Taiwan University Hospital Breast Cancer September 2003 Phase 2
NCT00538603 King Faisal Specialist Hospital & Research Center Epithelial Ovarian Cancer June 2005
NCT00434356 Genentech, Inc. Metastatic Breast Cancer March 2007 Phase 2
NCT01493843 Genentech, Inc. Non-Small Cell Lung Cancer January 20, 2012 Phase 2
NCT00565851 National Cancer Institute (NCI) Clear Cell Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Mucinous Adenocarcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinofibroma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal December 6, 2007 Phase 3
NCT01138137 OHSU Knight Cancer Institute Ovarian Carcinoma, Stage 3 or 4|Epithelial Ovarian Carcinoma|Primary Peritoneal Carcinoma June 2010 Phase 1
NCT01093300 Seoul National University Hospital In-stent Restenosis Lesion Phase 4
NCT00431080 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer August 2004 Phase 3
NCT00482391 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Dana-Farber Cancer Institute|GlaxoSmithKline Breast Cancer March 2007 Phase 2
NCT01732640 Sidney Kimmel Comprehensive Cancer Center|Vanderbilt-Ingram Cancer Center|National Comprehensive Cancer Network Squamous Cell Carcinoma of the Head and Neck December 2012 Phase 1|Phase 2
NCT02109328 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Bladder Cancer|Transitional Cell Carcinoma April 2014 Phase 2
NCT00568451 Mayo Clinic|National Cancer Institute (NCI) Melanoma (Skin) June 2006 Phase 2
NCT00493025 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Esophageal Cancer April 2005 Phase 2
NCT00004077 Medical Research Council|National Cancer Institute (NCI) Testicular Germ Cell Tumor May 1996 Phase 2
NCT01005329 National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Cell Carcinoma|Endometrial Clear Cell Carcinoma|Endometrial Papillary Serous Carcinoma|Stage I Endometrial Carcinoma|Stage II Endometrial Carcinoma|Stage III Endometrial Carcinoma|Stage IV Endometrial Carcinoma November 2009 Phase 2
NCT00005048 New York University School of Medicine|National Cancer Institute (NCI) Prostate Cancer April 1997 Phase 1
NCT02458911 iVascular S.L.U. Peripheral Vascular Disease May 2014
NCT01721746 Bristol-Myers Squibb Unresectable or Metastatic Melanoma December 2012 Phase 3
NCT00003242 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific February 1998 Phase 1
NCT00005078 City of Hope Medical Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2000 Phase 1
NCT00005840 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer|Stage IV Uterine Corpus Cancer July 2000 Phase 1
NCT00280787 UNC Lineberger Comprehensive Cancer Center|AstraZeneca|Amgen Non Small Cell Lung Cancer November 2003 Phase 2
NCT00006118 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Bladder Cancer July 1999 Phase 2
NCT00052312 European Organisation for Research and Treatment of Cancer - EORTC Endometrial Cancer September 2002 Phase 2
NCT00055835 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Urethral Cancer November 2002 Phase 2
NCT00002894 Medical Research Council|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1996 Phase 3
NCT00068757 European Organisation for Research and Treatment of Cancer - EORTC Breast Cancer August 2003 Phase 1
NCT00003379 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer November 1999 Phase 1|Phase 2
NCT00063258 M.D. Anderson Cancer Center Lung Cancer June 2003 Phase 2
NCT00002953 Medical Research Council|National Cancer Institute (NCI) Breast Cancer December 1996 Phase 3
NCT00077220 Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|National Cancer Institute (NCI) Lung Cancer June 2002 Phase 3
NCT00470301 National Cancer Institute (NCI) Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer April 2007 Phase 1|Phase 2
NCT00536939 Eli Lilly and Company|Genentech, Inc. Breast Cancer November 2007 Phase 2
NCT00433511 National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer December 2009 Phase 3
NCT00022191 European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI)|Groupe D'Etude des Tumeurs Uro-Genitales|Institute of Cancer Research, United Kingdom|Central European Cooperative Oncology Group|NCIC Clinical Trials Group|Southwest Oncology Group|German Association of Urologic Oncology|Spanish Oncology Genito-Urinary Group|Medical Research Council Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer May 2001 Phase 3
NCT00165035 Cordis Corporation|Conor Medsystems Coronary Disease May 2005 Phase 3
NCT01461915 Cantex Pharmaceuticals|Translational Drug Development Metastatic Pancreatic Cancer November 2011 Phase 2
NCT01008150 NSABP Foundation Inc|Puma Biotechnology, Inc. Breast Cancer October 2010 Phase 2
NCT00499291 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Cancer September 2006
NCT00006377 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Endometrial Cancer June 2000 Phase 2
NCT00974181 Cordis Corporation|Conor Medsystems Treatment of Symptomatic Ischemic Heart Disease January 2004 Phase 3
NCT00310011 Wake Forest University Health Sciences|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter June 1998 Phase 2
NCT02015676 Hoffmann-La Roche Breast Cancer July 2001 Phase 1|Phase 2
NCT00024310 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Unspecified Adult Solid Tumor, Protocol Specific September 2001 Phase 1
NCT00929162 AstraZeneca|ISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALI Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy June 2009 Phase 2
NCT00289263 MANTA 1 Study Italian Collaborative Group|Bristol-Myers Squibb Breast Cancer April 1998 Phase 3
NCT01971034 Instituto do Cancer do Estado de São Paulo Pancreatic Adenocarcinoma Advanced or Metastatic June 2011 Phase 2
NCT00140530 Deutsches Herzzentrum Muenchen|Bayerische Forschungsstiftung Muenchen Coronary Disease March 2004 Phase 4
NCT00004934 Nordic Society for Gynaecologic Oncology|European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer August 1999 Phase 3
NCT02427841 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Pancreatic Adenocarcinoma|Resectable Pancreatic Cancer January 2016 Phase 2
NCT01527864 Protgen Ltd Non Small Cell Lung Cancer May 2011 Phase 2
NCT00484315 Boston Scientific Corporation Coronary Artery Disease July 2007 Phase 3
NCT00002519 Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) Lung Cancer January 1997 Phase 1
NCT00553462 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer March 2008 Phase 2
NCT00856492 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer April 2010 Phase 2
NCT02934464 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Stomach Neoplasms December 2016 Phase 3
NCT00050960 Eisai Inc. Non-small Cell Lung Cancer May 2002 Phase 3
NCT00003612 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer April 1999 Phase 2
NCT00458315 Rigshospitalet, Denmark Unknown Primary Tumors May 2007 Phase 2
NCT02979392 Yung-Jue Bang|Seoul National University Hospital Advanced Solid Tumor December 2016 Phase 1
NCT00231075 ARCAGY/ GINECO GROUP Ovarian Cancer January 2001 Phase 2
NCT02315196 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer December 2014 Phase 2
NCT00473889 Merck Sharp & Dohme Corp. Stage IIIB or IV Non-Small Cell Lung Cancer May 2007 Phase 2|Phase 3
NCT00045630 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer January 2003 Phase 2
NCT02446574 Chinese Academy of Medical Sciences Esophageal Neoplasms July 2007 Phase 1|Phase 2
NCT02883062 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Invasive Breast Carcinoma|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma May 25, 2017 Phase 2
NCT00426556 Novartis Pharmaceuticals|Novartis Metastatic Breast Cancer July 2007 Phase 1
NCT00269828 CTI BioPharma NSCLC December 2005 Phase 3
NCT00883116 R-Pharm Endometrial Cancer August 2009 Phase 3
NCT01706120 National Cancer Institute, Naples|Mario Negri Institute for Pharmacological Research Ovarian Cancer October 2012 Phase 4
NCT00396929 University Hospital Tuebingen|Acrostak Stable or Unstable Angina Pectoris|Myocardial Ischemia August 2005 Phase 3
NCT00022217 Matrix Pharmaceutical|National Cancer Institute (NCI) Head and Neck Cancer November 2000 Phase 2
NCT02297217 AHS Cancer Control Alberta Esophageal Cancer September 2016 Phase 2
NCT00003387 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lung Cancer July 1998 Phase 3
NCT00193362 SCRI Development Innovations, LLC|Eli Lilly and Company|GlaxoSmithKline Lung Cancer June 2004 Phase 3
NCT01234038 Ionis Pharmaceuticals, Inc. Non-small Cell Lung Cancer November 2010 Phase 1|Phase 2
NCT00696956 University Hospital Tuebingen Atherosclerosis|Restenosis|Limb Ishemia April 2008 Phase 2|Phase 3
NCT01364012 Hoffmann-La Roche Non-Squamous Non-Small Cell Lung Cancer May 2011 Phase 3
NCT01643460 Indiana University Pancreatic Cyst|Pancreatic Intraductal Papillary-Mucinous Neoplasm|Cystadenoma, Mucinous|Papillary Mucinous Cystadenoma, Borderline Malignancy September 2009
NCT00189371 AGO Study Group Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum|Platinum Sensitve Relapse|Anemia February 2004 Phase 3
NCT00072215 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor April 2004 Phase 3
NCT00551122 University of Southampton|University Hospital Southampton NHS Foundation Trust Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor November 2006 Phase 1|Phase 2
NCT00449657 Leo W. Jenkins Cancer Center Non Small Cell Lung Cancer February 2007 Phase 2
NCT00850577 Bristol-Myers Squibb Non-small Cell Lung Cancer (NSCLC) June 2009 Phase 2
NCT00003065 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Cervical Cancer January 1997 Phase 2
NCT00003998 University of Glasgow|National Cancer Institute (NCI) Ovarian Cancer|Primary Peritoneal Cavity Cancer October 1998 Phase 3
NCT00574587 Albert Einstein College of Medicine, Inc.|Merck Sharp & Dohme Corp. Breast Cancer December 2007 Phase 1|Phase 2
NCT01491217 Hanmi Pharmaceutical Company Limited Advanced Metastatic Gastric Cancer|Recurrent Gastric Cancer May 2009 Phase 1|Phase 2
NCT00021333 Fox Chase Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer|Lung Cancer September 1999 Phase 2
NCT03126812 The Netherlands Cancer Institute|Merck Sharp & Dohme Corp. Ovarian Cancer Stage IV|Peritoneal Cancer|Fallopian Tube Cancer June 2017 Phase 1|Phase 2
NCT01329640 Instituto do Cancer do Estado de São Paulo|Fundação Faculdade de Medicina Locally Advanced HER2-positive Breast Cancer September 2010 Phase 2
NCT00626405 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Melanoma (Skin) August 2008 Phase 2
NCT01649947 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey Non-small Cell Lung Cancer|Advanced Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer December 23, 2011 Phase 2
NCT00278148 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lung Cancer October 2005 Phase 1|Phase 2
NCT00001384 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasms May 1994 Phase 2
NCT00111904 Theradex|National Cancer Institute (NCI) Pancreatic Cancer May 2005 Phase 2
NCT02413320 University of Kansas Medical Center Triple-negative Breast Cancer July 2015 Phase 2
NCT00189566 ARCAGY/ GINECO GROUP Ovarian Cancer|Fallopian Tube Cancer|Malignant Tumor of Peritoneum April 2004 Phase 2
NCT02214381 West German Study Group|TEVA Early Primary Breast Cancer in the Elderly. July 2014 Phase 2
NCT01822756 Incyte Corporation Metastatic Cancer|Metastatic Pancreatic Cancer April 2013 Phase 1
NCT02307812 Eli Lilly and Company Gastric Cancer|Gastroesophageal Junction Adenocarcinoma
NCT00003569 Roswell Park Cancer Institute|National Cancer Institute (NCI) Head and Neck Cancer|Lung Cancer|Neurotoxicity|Ovarian Cancer March 1998 Phase 1
NCT00598715 Deutsches Herzzentrum Muenchen Coronary Artery Disease October 2007 Phase 4
NCT00024401 Theradex|National Cancer Institute (NCI) Colorectal Cancer May 2001 Phase 2
NCT00201435 Norwegian Breast Cancer Group Breast Neoplasm March 2005 Phase 2|Phase 3
NCT00039039 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|National Cancer Institute (NCI) Lung Cancer February 2000 Phase 3
NCT01968915 Novartis Pharmaceuticals|Novartis Neoplasms November 2013 Phase 1
NCT00470366 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor March 2007 Phase 2
NCT00006108 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer August 1999 Phase 1|Phase 2
NCT00369070 Amgen Advanced Non-squamous NSCLC January 2007 Phase 2
NCT00933387 National Health Research Institutes, Taiwan|China Medical University Hospital|National Cheng-Kung University Hospital|Chi Mei Medical Hospital|Changhua Christian Hospital|Chang Gung Memorial Hospital Oral Cancer September 2009 Phase 2
NCT01694576 Jiangsu Cancer Institute & Hospital Nasopharyngeal Carcinoma September 2012 Phase 2
NCT00849472 GlaxoSmithKline|NSABP Foundation Inc Neoplasms, Breast July 2009 Phase 2
NCT01254526 Genentech, Inc. Breast Cancer December 2010 Phase 1
NCT00689715 Asan Medical Center Cystic Tumors of the Pancreas June 2006 Phase 2|Phase 3
NCT02637375 University of Chicago Breast Cancer May 2016
NCT01862081 Genentech, Inc. Breast Cancer, Non-small Lung Cancer July 16, 2013 Phase 1
NCT00026104 National Cancer Institute (NCI) Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer November 2001 Phase 2
NCT02608216 University of Pennsylvania Breast Neoplasm|Metastatic Breast Cancer|Rb+ Breast Cancer November 2015 Phase 1
NCT00483782 Medical Research Council|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer April 2006 Phase 3
NCT00591851 Memorial Sloan Kettering Cancer Center|Amgen|Genentech, Inc. Breast Cancer December 2004 Phase 2
NCT00070564 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer November 2003 Phase 3
NCT00003008 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|AIDS Associated Malignancies Clinical Trials Consortium Sarcoma June 1997 Phase 2
NCT02855788 Huashan Hospital|Seattle Integrative Cancer Center Metastatic Gastric Cancer|Locally Advanced Gastric Cancer May 2015 Phase 2
NCT01192165 GlaxoSmithKline Cancer September 2010 Phase 1
NCT00072319 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Pharmacia|Amgen Breast Cancer August 2003 Phase 2
NCT00768859 The Netherlands Cancer Institute Breast Cancer|HER2 Positive September 2008 Phase 2
NCT00009776 University of California, Davis|National Cancer Institute (NCI) Lymphoma March 2001 Phase 1
NCT02272790 AstraZeneca Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation January 30, 2015 Phase 2
NCT02546232 Oslo University Hospital Breast Cancer March 2015 Phase 2
NCT02389751 M.D. Anderson Cancer Center|Synta Pharmaceuticals Corp. Esophageal Cancer April 2015 Phase 1
NCT01229930 University of Glasgow|National Cancer Institute (NCI) Cervical Cancer June 2010 Phase 2
NCT02713386 NRG Oncology|National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Serous Neoplasm|High Grade Ovarian Serous Adenocarcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage III Fallopian Tube Cancer|Stage III Ovarian Cancer|Stage III Primary Peritoneal Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB May 2016 Phase 1|Phase 2
NCT01366131 Genentech, Inc. Non-Squamous Non-Small Cell Lung Cancer June 2011 Phase 2
NCT00079287 Japan Multinational Trial Organization|National Cancer Institute (NCI) Lung Cancer March 2001 Phase 3
NCT03020329 Sun Yat-sen University Nasopharyngeal Carcinoma|Children January 2017 Phase 2
NCT00003127 Southwest Oncology Group|National Cancer Institute (NCI) Endometrial Cancer February 1998 Phase 2
NCT00460317 Amgen|Takeda Non-Small Cell Lung Cancer July 2007 Phase 3
NCT02117817 Rutgers, The State University of New Jersey|Rutgers Cancer Institute of New Jersey|National Cancer Institute (NCI) Ovarian Cancer|Endometrial Cancer|Recurrent Ovarian Cancer|Recurrent Endometrial Cancer February 2015 Phase 1
NCT00005819 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific April 2000 Phase 1
NCT00404404 Premiere Oncology|National Cancer Institute (NCI) Breast Cancer October 2006 Phase 2
NCT02962232 ZhuHai Cardionovum Medical Device Co., Ltd. Peripheral Artery Disease November 2016
NCT02470585 AbbVie|Gynecologic Oncology Group|Australia New Zealand Gynaecological Oncology Group Ovarian Cancer|Ovarian Neoplasm July 2015 Phase 3
NCT02996214 Nanjing Luye Sike Pharmaceutical Co.,Ltd. Lung Squamous Cell Carcinoma November 2016 Phase 4
NCT00948675 Eli Lilly and Company Advanced Non-Small Cell Lung Cancer September 2009 Phase 3
NCT01594099 Health Science Center of Xi’an Jiaotong University Cervical Cancer April 2012 Phase 2
NCT02962141 ZhuHai Cardionovum Medical Device Co., Ltd. Peripheral Arterial Disease|Fistula October 2016
NCT02766582 Medical College of Wisconsin Ovarian Cancer October 2016 Phase 2
NCT00798954 Vulnerable Plaque Society Ischemic Heart Disease|Restenosis June 2007 Phase 4
NCT00003035 Georgetown University|National Cancer Institute (NCI) Breast Cancer March 1997 Phase 2
NCT00004887 The Christie NHS Foundation Trust|National Cancer Institute (NCI) Lung Cancer January 1999 Phase 3
NCT02810457 Centus Biotherapeutics Limited Carcinoma, Non-Small-Cell Lung June 2016 Phase 3
NCT00003050 University of Southern California|National Cancer Institute (NCI) Breast Cancer April 1997 Phase 2
NCT00777673 University of Tennessee Cancer Institute|National Comprehensive Cancer Network|Celgene Corporation|Genente